Try this (it may not look great, but possibly a little better): Select all of below text. Copy. Open your blog. Paste into blog.

Hydroxychloroquine.... the debate...

 

 First I would like to introduce myself so that you can evaluate my experience, education, affiliations etc. Attachment one is a series of write-ups prepared by the Department of Defense, the state of California, the U.S. Army,  the Department of Health and Human Services, etc. in conjunction with my scientific advisory activities with multiple  US government, state of California, Los Angeles County and nonprofit advisory organizations such as RAND Corporation, the center for strategic International studies, etc.

 

 The second attachment is a link to a Senate hearing. By way of disclosure, One of the witnesses in favor of the early treatment use of hydroxychloroquine is from Baylor medical school. I taught at Baylor University when I was stationed at the  U.S. Army medical school.

 

 The Third attachment is a multilayered program including airflow management; rapid inexpensive testing; prophylactic treatment; early therapy.

 

 ATTACHMENT ONE:

 

1.From US Department of Defense : Howard Laitin Torrance : California : United States

 

Harvard, Ph.D.(Economics; Public Health). National Defense University Graduate Program; U.S. Army Command and General Staff College;  Career Officer Course; Lt. Col. USA (Retired).

 

 Chief Scientist, Hughes Aircraft Company & Raytheon  Corporation (Retired). Adjunct Professor of Engineering, USC. Clinical Associate Professor of Public Health, UCLA. Registered Professional Engineer (California). 

 

US Military Advisory Groups to: Egypt, Jordan, Saudi Arabia; Iranian Nuclear Program: Review of technology and sustainable development. Iraqi Intervention: Review of alternatives and probable outcomes.

 

Consultant/Advisor: Center for Strategic and International Studies; Hudson Institute; Institute for Defense Analyses; Rand Corporation; Government Accountability Office; Office of Management and Budget; Department of Defense; Department of Health and Human Services; Department of Transportation; US Treasury. Army Science Board,; . National Highway and Traffic Safety Administration; National Science Foundation; US Customs Service;  US Public Health Service.

 

 Chairman Environmental Quality Programs: Governor Ronald Reagan, Governor Jerry Brown.

 

2.     From the state of California  Howard Laitin, Record of Service - Partial

 

I.              General

        A.  Harvard, Ph.D.(Economics Public Health).

        B.  Lt. Col. USAR (Retired).  Enlisted Service through rank of SFC;  commissioned service through rank of Lt. Col.

        C.  Chief Scientist, Hughes Aircraft, (Retired)

        D.  Adjunct Professor of Engineering, University of Southern California

        E.  Clinical Associate Professor of Public Health, University of California, Los Angeles.

        F.  Registered Professional Engineer (California)

 

II.            Intelligence/Military Operations(Consultant/Advisor)

        A.  Center for Strategic and International Studies (CSIS)

        B.  Hudson Institute

        C.  Institute for Defense Analyses (IDA)

        D.  Rand Corporation

 

III.           Policy Development and Evaluation(Consultant/Advisor)

        A.  Government Accountability Office (GAO)

        B.  Office of Management and Budget (OMB)

        C.  Dept. of Defense, Office of Secretary

        D.  Dept. of Health and Human Services, Office of the Secretary

        E.  Dept. of Transportation, Office of the Secretary

        F.  US Treasury, Office of Secretary

        G.  Army Science Board, Member

        H.  National Highway and Traffic Safety Administration

        I.  National Science Foundation

        J.  US Customs Service

        K.  US Public Health Service

 

IV.           Review of program and policy alternatives (Advisor/Reviewer)

       A.  Iranian Nuclear Program (until 8/04):  With professor Najm Meshkati.  Review of reports (prepared by Iran’s Center for Strategic Research (CSR);  Ministry of Foreign Affairs;  Atomic Energy Organization;  Ministry of Science, Research and Technology, etc.) on such topics as nuclear technology and sustainable development, Iran’s nuclear fuel cycle program, etc., to be presented at various Iranian organized international meetings.

       B.  Iraqi Intervention:  With Stan Katten (Rand Alumni and Policy Forum).  In-depth study and evaluation of the alternative responses and courses of action regarding the Iraq threat that had been available to the United States (President George W. Bush) at the beginning of 2003 and an assessment, for each, of their probable outcomes.

       C.  Military Assistance Programs

             1.  US Military Advisory Group to the Government of Egypt

             2.  US Military Advisory Group to the Government of Jordan

             3.  US Military Advisory Group to the Government of Saudi Arabia (National Guard)

 

V.            Development of Environmental Quality Programs (Chaired Councils and Working Groups) 

       A.  Board of Supervisors, Los Angeles County (public member of several boards)

       B.  State of California

             1.  Gov. Ronald Reagan (Chaired Task Forces, Committees and Councils)

             2.  Gov. Jerry Brown (Chaired Task Forces, Committees and Councils)

             3.  Assembly Science and Technology Committee

 

3.Office of the Surgeon General, U.S. Army

 

 

 

 

4.   page 1 of three; US Department of Health and Human Services

 

 

 

 

 

 

5. from the legal departments of General Motors, Raytheon, Hughes Aircraft had three major  Washington DC law firms.

 

 

 

HOWARD LAITIN SUPPORT TO HUGHES AND GM LEGAL 1986-1992]

 

1992

• Supported GM Legal on a  very significant patent infringement case.

Thoroughly explored and documented the state-of-the-art [prior to 1957] for a wide range of

relevant technologies.

— Conducted 350+ interviews with leading university, government and industry scientists.

— Conducted thorough search of the technical literature. Screened several thousand technical articles and reports. Located 400+ potentially relevant articles for further evaluation. Prepared 25+

summary evaluation reports for GM and their law firms.

 

• Supported Corporate and RSG Legal on current civil litigation [for both Hughes claims

and Hughes counter-claims].

— Helped screen and evaluate a large mass of technical and program planning materials that had been obtained by Hughes and by Kirkland and Ellis as a result of discovery actions.

 

1991

• Supported Corporate Legal and MSG Legal in successfully refuting allegations of defective pricing and failure to disclose.

— Analyzed and helped document the appropriateness of the pricing strategy that MSG had utilized on the bids that had been questioned.

— Researched and documented the availability of "open sources" for certain Government and competitor information that had been located in MSG files. Prepared a matrix showing the multiple possible prior public sources for all of the information that had been questioned.

 

1990

• Supported Corporate Legal and King and Spalding in successfully refuting allegations

concerning the misuse of classified budget information by senior Hughes executives.

Through a very extensive search, replicated, from "available open sources," the documents and the specific data that had been questioned. Obtained a signed statement from DoD legal confirming the

availability of the questioned data in a specific DoD data bank and affirming that the former MSG Executive had both the required security clearance and the required need-to-know to request the data, and that upon his request, the former MSG Executive would have been granted access to this data.

 

 • Supported GM Legal in locating and obtaining qualified Hughes Aircraft technical support for the successful determination that the Allison Gas Turbine engines were not the cause of the Piper Alpha drilling platform disaster.

— Conducted comprehensive (confidential) company-wide technical resource search to identify and qualify extremely skilled photo enhancement and photo analysis specialists (and the necessary r

hardware and programming resources].

— Worked with a GM contractor [Failure Analysis, Inc.] to validate a model which helped document the point of origin and the direction of the flow of the fire.

 

1988

• At the request of John Kuelbs [who responded to the request of Donald Atwood], recruited a small team that successfully worked with Delco Systems Operations and the U.S. Government to rescind the Government's Contractor System Status Review decision which made DSO ineligible for the award of any additional U.S. Government contracts. Met with DSO and Government personnel and surveyed DSO's operations and files to identify significant problems and their basic causes.

— Helped prepare summary reports outlining the problems and proposing a definitive "get-well plan."

— Helped obtain Government and DSO acceptance of the plan.

— Assisted on the implementation activities which successfully reversed the Government's original decision.

 

• Later, in response to a request from Dr. Currie, provided "very substantial assistance"

to Bob Roderick in preparing a thorough assessment of the technical and market status of DSO's

various product lines.

 

• Organized Army-mandated Govenment/Industry Advisory Review Panel which

worked with the Hughes C-NITE Program Office and with AVSCOM to develop an acceptable [to

the Government and to Hughes], technically feasible, cost-effective corrective action plan which

would improve to the point of acceptance the then unacceptable C-NITE EMI conditions. These

conditions constituted "a very critical technical lean" which threatened the possible assessment of

damages against Hughes Aircraft

 

• At the request of GM Corporate Environmental Activities Staff, helped GM find and

qualify an expert consulting company to locate and remediate the effects of hazardous waste leaks

from several hundred underground storage tanks.

 

• Organized the EDSG portion of the technical program for the visit of the Howard

Hughes Medical Institute Board to Hughes.

 

• Evaluated BFVS warranty clause impacts. Recommended changes.

— Reviewed the Program's technical and performance data and developed estimates of possible impacts of the then current contract an

plan.

— Constructed a computer model for detailed analysis and evaluation of alternatives. Made recommendations to EDSG Legal and Contracts and to the HAC BFVS Program Office.

 

1986

• In support of EDSG Legal and M-l Contracts, supported the M-l claims [successfully settled for approximately $2.5M].

— Helped determine the specific causes of action and potential strategies.

— Helped document the basic facts and supporting detail. [50% ofthe cost analysis documentation; 80% of the historical information

documentation; and 75% of the participant interviewing documentation.]

— Identified a legal precedent which required the Government to

"start the clock" moving for paying interest to Hughes on the claim.

 

• Supported the visit of the GM Board of Directors to Hughes.

 

• Participated in developing the BFVS Corrective Action Plan for the U.S. Army.

— Developed a computerized through-put model to estimate BFVS

deliveries in response to various proposed program actions.

Analyzed the financial impacts and expected schedule results of

various alternative "get well" approaches.

Worked with BFVS Contracts on developing appropriate clauses and

supporting data for the contract negotiations.

Assisted BFVS Contracts by participating in the Government's

"fact finding" visits.

 

• Worked with EDSG Legal on developing the strategy and the detailed submissions

which successfully countered the potential $6M claim against Hughes on the M-60 Economic

Escalation Clause. Developed the fundamental approach, structured the formula, and

directed the required computational efforts.

Worked with M-60 Contracts on both preparing and making the presentations to the MICOM Contracts Office which resulted in their favorable decision. 

 

 

 

 

 

 

6.  And  finally read Gen Colin Powell’s view

MY AMERICAN JOURNEY by Colin Powell [Chapt 7- White House Fellow]

 

Fred Malek, Joe Laitin, and Velma Baldwin were my mentors. In all the schools of political science, in all the courses in public administration throughout the country, there could be nothing comparable to this education.

 

I knew where I wanted to spend my year as a White House Fellow—at an agency whose very name would cause most eyelids to droop, OMB, the Office of Management  and Budget. I knew from my MBA courses and my time in the Pentagon that budgets are to organizations what blood is to the circulatory system. And OMB had its hand on every department's jugular. It is one of the least understood yet most powerful federal agencies in Washington.

 

 ATTACHMENT  TWO:   Recent  Senate hearing. I will stake my lifelong professional reputation on Prof. Harvey Risch  being 100% correct.

 

https://www.youtube.com/watch?v=ftq6lmRlKgQ&feature=emb_logo

 

 

 

 

 ATTACHMENT  THREE:  Multilayered program  to safely reopen the US society and the US economy.

 

 

Subject: RESTORING AMERICA’S  ROBUST, ECONOMIC, EDUCATIONAL, SOCIAL, RELIGIOUS, AND OTHER COMMUNAL ACTIVITIES

 

 

 

 I believe that all the elements are present to fully reopen all  schools,  churches, synagogues  mosques,  offices, industrial activities, commercial activities,  social and athletic activities, etc.  I would like to  propose what I  believe would  be a safe, effective and economical program which will give the  the entire American population more assurance of  health and safety than do the current pandemic lockdown mandates.

 

 

Howard Laitin 4916 White Court Torrance CA 90503-2245   hlaitin@gmail.com   message phone + fax  310-370-5011

 

 

 

 

1. There are simple, inexpensive procedures that would guarantee safety  at a level  much higher than that which is claimed for the   current  NY  and California lockdown mandates’. 

 

 2. I am attaching an introductory  memo which should  give  individual entities the ability to proceed with the specifics that are tailored to the individual needs of their communities. Also, contained in this memo are first cut leads, who should then be able to connect  each of the various entities  with specific advisors that COULD   help them develop their individualized programs. Again note , what is provided is information and links to qualified individuals who could then provide the  necessary information for each organization and community to develop their own program.

 

 3.   Basically, I am recommending:

 

 a.  All classrooms, offices, etc.  be equipped with air scrubbers and other ventilation and air purification techniques to make the indoors circulation and air purity at least as robust as the outdoor circulation  currently is;There is  an abundance of available information on the  use of fans, etc. to increase indoor air circulation.  There  is an increasing amount of information being released about systems utilizing   ultraviolet, ozone, etc. to  kill the airborne virus].  Also, all surfaces will be wiped down  every day with a treatment that has already been approved by the US EPA (which is certified to kill the coronavirus for at least one week).

 

 

 b.prophylactic use   of hydroxychloroquine; 

 

c.Inexpensive, rapid, easy to read tests  which could be  self-administered to shoppers, students, religious worshipers, commercial and service workers, etc. who after five  to  15 minutes would then be shown to be noninfectious and thus not subject to masking or  social distancing requirements. 

 

 

d.  Prompt and effective out-patient  treatment to those  who’re shown to infected [ rather than having them wait  at home to see what happens to them   in terms  their developing  significant symptoms [and the resulting  medical complications and disabilities] ,which is the current standard  medical practice. [Should any participant(s)  present with any symptoms of the virus, then they, their  family members and others in very close contact with them  should be  placed immediately in a treatment program.  I would suggest that if the patient was on hydroxychloroquine as a prophylactic then he should be switched to Ivermectin   as a therapeutic.]

. 

4.     Benefits for the  community  

 

 

a. Substantially reduces the likelihood of transmission of the virus;

 

b. Provides protection for  the most vulnerable [the aged,  those with one or more  existing medical conditions such as obesity, diabetes, heart problems, etc.]; 

 

c. Provides  prophylactic protection for those who may become   exposed  to the  virus ….and  if already exposed  to the virus, provides the early" fire extinguisher" type of protection against the increasing  buildup of the  patient's viral load.

 

d. At a minimum the community will achieve substantially reduced infection rates probably similar to those  Third World countries which routinely utilize hydroxychloroquine as an over-the-counter prophylactic against yellow fever. Data shows that Covid-19  infection rates in those countries has been far below that the infection rates of Europe, the United States, China etc.

 

 e If it works as  well  as it has reported in various  peer-reviewed cited studies, then lockdowns, social distancing, masks, and other restrictions on community  life will have been  proved to be  unnecessary and  the community will be able to  emerge from its current social and economic Covid-19  quagmirereturn and return  to its robust pre-pandemic life. 

 

5. Costs 

 

 a. Medically  hydroxychloroquine;has been in use for decades both as a prophylactic and in certain conditions such as  lupus and experience shows that is safe no medical consequences] The drug is a generic. It is low cost. Many dozens, possibly hundreds of drug manufacturers now manufacturing supplements, could easily manufacture this drug in quantity at low cost and meet the highest standards of purity.

 

 

 

6. BACKGROUND READING & LINKS

 

a.  Dr. Harvey Risch of the Yale School of Public Health [harvey.risch@yale.edu ….”The Key to Defeating COVID-19 Already Exists[ hydroxychloroquine]. We Need to Start Using It “…..]

 

b.  How to Beat COVID-19 with Daily Quick Tests At Home: Summary by Dr. Mina.  Date: August 30, 2020    https://youtu.be/AZWuyvBAWWQ

 

c.   I  recommend that you listen to the entire video …. approximately one hour, 24 minutes.  In this video 9  licensed and practicing physicians discuss their treatment experience.  [  The interviewer is Charlie Kirk. Link one is YouTube, but since  it might be taken down, here is   Link two ( ISRAPUNDIT.)] 

 

 https://www.youtube.com/watch?v=nn2P4-cK_K8&feature=youtu.be

 

https://www.israpundit.org/the-charlie-kirk-show-nine-doctors-speak-out/

 

d.. Video : “ Why Lupus Patients May Hold The Key To Whether Hydroxychloroquine Could Work"  -  link : Why Lupus Patients May Hold The Key To Whether Hydroxychloroquine Could Work – Part 2 

 https://www.doctoroz.com/episode/covid-19-pandemic-why-lupus-patients-may-hold-key-whether-hydroxychloroquine-could-work-keep?video_id=6147739736001

 

https://www.doctoroz.com/episode/covid-19-pandemic-why-lupus-patients-may-hold-key-whether-hydroxychloroquine-could-work-keep

 

 

 

7.    TESTING  INFORMATION

 

  TESTING people, who carry the coronavirus whether they have obvious signs of infection or do not have obvious signs of infection, will test positive before they become carriers  on numerous rapid tests that are nearly immediately available. you  should do your  own evaluation and not depend upon prior United States  approval . Dr Mina explains why  the existing structure and charters responsibility of the various existing US government medical institutions  make them a roadblock and not  functioning highway.

 

 

 

Subject: How to Beat COVID-19 with Daily Quick Tests At Home: Summary by Dr. Mina.  Date: August 30, 2020    https://youtu.be/AZWuyvBAWWQ

 

 

<unknown.tiff>

 

<MIMA TEST FEATURE COMPARISONS\.png>

 

 

 

 

 

 

 

<unknown_1.tiff>

 

<MINA TEST .png>

 

 

Thus give each person [ either periodically or on their way into the  classroom, service, restaurant, game/event, transportation, office, store, etc] a simple, inexpensive screening test that can be immediately read by anyone, without any special laboratory equipment.

 

To  get there, it is necessary to  recognize the major  difference between diagnostic tests – which can detect ultra-low levels of viral RNA – and public health  screening tests, which tell you whether you are contagious. 

 

Diagnostics are what doctors use to know why someone is sick. They are a specific kind of test. A diagnostic that a doctor orders must be very good to do what it is meant to do – determine if someone is sick for a specific reason. So it needs to be high sensitivity and high specificity, there’s little wiggle room. 

 

 A public health [surveillance]  test indicates  that something  is present which warrants further  examination and possible follow-up.[ The criticism of many of these tests is that they fail to detect a positive during the first several days  of the infection as the virus count goes up but is still below the threshold of sensitivity. If the tests are administered  once a week this  should not matter since the person  who is  infected becomes a  transmitter only after several days  [? Check out and insert the correct  exact  range] and the second test a week later  should read positive.]

 

 As background,view the following video download https://youtu.be/qKM4MIrfr4k      it is an interview by Dr. Kyle Allred [cofounder of MEDCRAM   a video educational site with Bobbi Brooke Herrera PhD, cofounder of e25 Bio. Dr Allred   is a useful switchboard contact.  This  means he  maintains a wide network and has an inkling of lots of things happening in lots of places. He can be reached at    customers@medcram.com   Dr Herrera  can be reached at   info@e25bio.com.    He should be a good information source for the current status of  simple screening test developments at a large number of firms.  These two discussions should  yield a lot of  payoff in terms of useful contacts, information, etc.  MedCram Update 98 for context on rapid daily quick tests and Dr. Mina's research | 

https://youtu.be/h7Sv_pS8MgQ

 

 

8.  MEDICATION  INFORMATION

There are two well-established medications both of which have a long history of safe usage.[ A. Hydroxychloroquine;  B   Ivermectin]

 

A. HYDROXYCHLOROQUINE

 

a. Approximately one hour, 24 minutes.   10   licensed and practicing physicians discuss their treatment experience.  [  The interviewer is Charlie Kirk. Link one is YouTube, but since  it might be taken down, here is   Link two ( ISRAPUNDIT.)] 

 

 https://www.youtube.com/watch?v=nn2P4-cK_K8&feature=youtu.be

 

https://www.israpundit.org/the-charlie-kirk-show-nine-doctors-speak-out/

 

b... Video : “ Why Lupus Patients May Hold The Key To Whether Hydroxychloroquine Could Work"  -  link : Why Lupus Patients May Hold The Key To Whether Hydroxychloroquine Could Work – Part 2 

 https://www.doctoroz.com/episode/covid-19-pandemic-why-lupus-patients-may-hold-key-whether-hydroxychloroquine-could-work-keep?video_id=6147739736001

 

 

c.. From HARVEY A. RISCH, MD, PHD , PROFESSOR OF EPIDEMIOLOGY, YALE SCHOOL OF PUBLIC HEALTH ….”The Key to Defeating COVID-19 Already Exists[ hydroxychloroquine]. We Need to Start Using It “

As professor of epidemiology at Yale School of Public Health, I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals. I am usually accustomed to advocating for positions within the mainstream of medicine, so have been flummoxed to find that, in the midst of a crisis, I am fighting for a treatment that the data fully support but which, for reasons having nothing to do with a correct understanding of the science, has been pushed to the sidelines.

As a result, tens of thousands of patients with COVID-19 are dying unnecessarily. Fortunately, the situation can be reversed easily and quickly.I am referring, of course, to the medication hydroxychloroquine. When this inexpensive oral medication is given very early in the course of illness, before the virus has had time to multiply beyond control, it has shown to be highly effective, especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc.

On May 27, I published an article in the American Journal of Epidemiology (AJE) entitled, “Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis.” That article, published in the world’s leading epidemiology journal, analyzed five studies, demonstrating clear-cut and significant benefits to treated patients, plus other very large studies that showed the medication safety

 

 

d.   Hydroxy Hysteria Reaching a Fever Pitch [Exerpts]

By Brian C. Joondeph, M.D.  American Thinker  7-31-20 Ever since President Trump mentioned hydroxy as a possible therapeutic, the media have castigated it as worse than rat poison. They’ve criticized any use of it in a constant barrage of fear, telling everyone that this 60-year-old drug would kill anyone who dared tak 8-e it.

 

Hydroxy was FDA-approved in 1955 and is taken for lupus and rheumatoid arthritis. FDA approval means the approved drug is both efficacious and safe. All of a sudden, after 60 years, the FDA decided hydroxy is no longer safe because of, “serious heart rhythm problems and other safety issues, including blood and lymph system disorders, kidney injuries, and liver problems and failure.” If it is so unsafe, why did the FDA not rescind its 60-year-old approval?

 

It is worth noting that diseases treated by hydroxy for the past half century can cause these problems as well. As can COVID, which if severe, can also cause death. So, the FDA deems it safe to treat those sick with lupus and autoimmune diseases with hydroxy but not those sick or hospitalized with COVID.Several days ago, a group of physicians called “America’s Frontline Doctors held a press conference in front of the U.S. Supreme Court building discussing the  coronavirus and hydroxychloroquine. One physician in particular, Dr Stella Immanuel, gave an impassioned shout-out for hydroxy:

 

 I have personally treated over 350 patients with COVID. Patients that have diabetes, patients that have high blood pressure, patients that have asthma, old people … I think my oldest patient is 92 … 87-year old. And the result has been the same. I put them on hydroxychloroquine, I put them on zinc, I put them on Zithromax, and they’re all well.

. 

Some studies say hydroxy doesn’t work, like giving hydroxy to patients too sick to benefit, already on a ventilator, as in the VA study. Other studies found safety concerns and were published in prestigious medical journals like The Lancet and The New England Journal of Medicine, only to be discovered to be bogus and retracted. Still other studies, as from the Henry Ford Health System noted that hydroxy cut the death rate in half.

 

This chart from the Association of American Physicians and Surgeons shows a much lower case fatality rate in countries where hydroxy is allowed and encouraged rather than banned or discouraged.

 

 

 

e.Hydroxychloroquine by Emily Benedek  The Tablet 8-14-20

https://www.tabletmag.com/sections/science/articles/hydroxychloroquine-morality-tale

Early in the coronavirus pandemic, a survey of the world’s frontline physicians showed hydroxychloroquine to be the drug they considered the most effective at treating COVID-19 patients. That was in early April, shortly after a French study showed it was safe and effective in lowering the virus count, at times in combination with azithromycin. Next we were told hydroxychloroquine was likely ineffective, and also dangerous, and that that French study was flawed and the scientist behind it worthy of mockery. More studies followed, with contradictory results, and then out came what was hailed by some as a definitive study of 96,000 patients showing the drug was most certainly dangerous and ineffective, and indeed that it killed 30% more people than those who didn’t take it. Within days, that study was retracted, with the editor of one of the two most respected medical journals in the Western world conceding it was “a monumental fraud.” And on it went.

 

 

f.Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows July 02, 2020

https://www.henryford.com/news/2020/07/hydro-treatment-study

 

DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new studypublished by Henry Ford Health System. In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020 across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19. 

 

The study was published today in the International Journal of Infectious Diseases, the peer-reviewed, open-access online publication of the International Society of Infectious Diseases (ISID.org). 

 

Patients treated with hydroxychloroquine at Henry Ford met specific protocol criteria as outlined by the hospital system’s Division of Infectious Diseases. The vast majority received the drug soon after admission; 82% within 24 hours and 91% within 48 hours of admission. All patients in the study were 18 or over with a median age of 64 years; 51% were men and 56% African American.

 “The findings have been highly analyzed and peer-reviewed,” said Dr. Marcus Zervos, division head of Infectious Disease for Henry Ford Health System, who co-authored the study with Henry Ford epidemiologist Samia Arshad. “We attribute our findings that differ from other studies to early treatment, and part of a combination of interventions that were done in supportive care of patients, including careful cardiac monitoring. Our dosing also differed from other studies not showing a benefit of the drug. And other studies are either not peer reviewed, have limited numbers of patients, different patient populations or other differences from our patients.” Zervos said the potential for a surge in the fall or sooner, and infections continuing worldwide, show an urgency to identifying inexpensive and effective therapies and preventions. “We’re glad to add to the scientific knowledge base on the role and how best to use therapies as we work around the world to provide insight,” he said. “Considered in the context of current studies on the use of hydroxychloroquine for COVID-19, our results suggest that the drug may have an important role to play in reducing COVID-19 mortality.” 

The study also found those treated with azithromycin alone or a combination of hydroxychloroquine and azithromycin also fared slightly better than those not treated with the drugs, according to the Henry Ford data. The analysis found 22.4% of those treated only with azithromycin died, and 20.1% treated with a combination of azithromycin and hydroxychloroquine died, compared to 26.4% of patients dying who were not treated with either medication. “Our analysis shows that using hydroxychloroquine helped save lives,” said neurosurgeon Dr. Steven Kalkanis, CEO, Henry Ford Medical Group and Senior Vice President and Chief Academic Officer of Henry Ford Health System. “As doctors and scientists, we look to the data for insight. And the data here is clear that there was benefit to using the drug as a treatment for sick, hospitalized patients.”  

 

Henry Ford Health System, as one of the region’s major academic medical centers with more than $100 million in annual research funding, is involved in numerous COVID-19 trials with national and international partners.  Henry Ford Health System is a $6.5 billion integrated health system comprised of six hospitals, a health plan, and 250+ sites including medical centers, walk-in and urgent care clinics, pharmacy, eye care facilities and other healthcare retail. Established in 1915 by auto industry pioneer Henry Ford, the health system now has 32,000 employees and remains home to the 1,900-member Henry Ford Medical Group, one of the nation’s oldest physician groups. An additional 2,200 physicians are also affiliated with the health system through the Henry Ford Physician Network. An active participant in medical education and training, the health system has trained nearly 40% of physicians currently practicing in the state and also provides education and training for other health professionals including nurses, pharmacists, radiology and respiratory technicians. 

 

 

g..  Concerning Hydroxychloroquine .Everyone that I deal with says the secret of success is  early  use… yet  all the negative  reports that I’ve seen are  based on relatively late use

 

h.. My oldest granddaughter and her entire team were  on a prophylactic regime of Hydroxychloroquine  during  their assignment to Africa.   No one suffered from any side effects.

 

i..  Encino CA   Harvard Medical School MD;  board certified in internal medicine and other specialties; UCLA internship  and residency and now on the clinical faculty of UCLA; clinic director;  in private practice including infectious diseases for more than 30 years has successfully used Hydroxychloroquine   with many  patients.[  current data to be obtained.] He likens  its use to a fire extinguisher and says it is  effective very early in the game when symptoms first appear  before  the  virus really gets a toe hold. [“So far in my clinical experience, I can tell you that Hydroxychloroquine/Azithromycin combo has been 100% effective for my CoV patients, when used in conjunction with all of the Integrative …. I employ.  Needs to be given early enough in the course of the illness to be maximally effective.  Much like a fire extinguisher can put out a small kitchen fire, but if a house is engulfed in flames, you need a fire hose.  Doesn’t mean fire extinguishers don’t work for house fires, just need to be used early in the event……”]

 

j.     Phoenix AZ Tufts medical school MD; board-certified  in anesthesiology and pain management; clinic manager   tells me that all of his associates  prescribe Hydroxychloroquine   and would use it in their own families.

 

k..     Torrance CA   a local physician prescribed it to both of his elderly parents  [ mother late 80s, father early 90s] who tested positive for Covid-19 just before both were taken to the hospital in serious condition. Although  the expectations were that one or both  would die-both survived and are  now both well on the road to recovery. ironically, the mother was selected for a medical test but received the placebo. Otherwise except for Hydroxychloroquine  she had no other medication. The physician at the hospital claimed that Hydroxychloroquine  was ineffective. The son , in a major article ,claimed otherwise. If the report was to be utilized by CDC they would take the hospital position and chalk it up that it was “ineffective.”

 

l.     Coronavirus at Texas Nursing Home – Hydroxychloroquine Treatment Saves All But 1 Patient  

The Resort at Texas nursing home had an outbreak of coronavirus that infected 56 residents and 33 staff members. “Two of our residents had symptoms and that’s when we tested everybody,” said nursing home Executive Director Jan Piveral. 56 residents and 33 staff members were COVID-19 positive. “Our Goal was to make sure we could shelter them in place so we don’t spread it to other people,” Armstrong said. “Then also at the same time treat them so they would get better.”Dr. Robin Armstrong immediately administered hydroxychloroquine to the residents and staff members along with Zpac and Zinc. Only one nursing home patient died since the doctor prescribed the hydroxychloroquine. 55 made it.

 

When Armstrong began administering Hydroxychloroquine to it was controversial but appeared promising.“If we didn’t make the decision quickly then we could potentially lose 15 to 20% of the residents which was not an option,” said the Doctor. Armstrong’s approach was to begin administering Hydroxychloroquine a Zpac and Zinc just as soon as a resident first started showing symptoms.The patients were being monitored daily. “We did EKGs on each of these patients to make sure they didn’t have the cardiac side effects that everyone talks about,” Armstrong said. “None of our patients did.”Armstrong doesn’t call the Hydroxychloroquine a cure and is aware of all the recent reports that say the drug shouldn’t be used to treat COVID-19.But he points out only one of the nursing homes COVID-19 patients has died.“Everyone who got on treatment who started on treatment is actually doing really well,” he said.

 

m.    Information from  Monroe, New York

 

Since 3/15/20, my team has seen approximately 1354 patients in Monroe, New York with either

test proven or clinically suspected coronavirus infection. The majority of the patients were

treated with only supportive care. The patients with shortness of breath or who are in the high

risk category were treated with the above regimen (approximately 405 patients at this point)..

Of this group and the information provided to me by affiliated medical teams, we have had two

deaths, six hospitalizations for pneumonia, and four intubations (all extubated now). In addition,

I have not heard of any negative side effects other than approximately 10% of patients with

temporary nausea and diarrhea.

 

In sum, my urgent recommendation is to initiate treatment in the outpatient setting as soon

as possible in accordance with the above. Based on my direct experience, it prevents acute

respiratory distress syndrome (ARDS), prevents the need for hospitalization and saves lives.

 

Conclusion: TREAT AS EARLY AND AS AGGRESSIVELY AS POSSIBLE IN THE OUTPATIENT SETTING

 

 

n.    MORE THAN   2,304    PHYSICIANS WHO ARE CURRENTLY SUCCESSFULLY TREATING  PATIENTS INFECTED WITH THE COVID-19  REPORTED  THEIR  “ANECDOTAL EVIDENCE” OF THEIR  SUCCESS WITH THEIR PATIENTS UTILIZING HYDROXYCHLOROQUINE

 

 An international  survey conducted by Sermo, a global health care polling company, of 6,227 physicians in 30 countries found that 37% of those treating COVID-19 patients rated hydroxychloroquine as the “most effective therapy” from a list of 15 options.

 

The survey also found that the most commonly prescribed treatments are analgesics (56%), azithromycin (41%) and hydroxychloroquine (33%).

 

Hydroxychloroquine, which is sold under the brand name Plaquenil, was prescribed mainly in the United States for the most severe cases, but not so in other countries.

 

“Outside the U.S., hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the U.S. it was most commonly used for high risk diagnosed patients,” the survey found.

 

The 30 nations surveyed included those in Europe, Asia, North America and South America, as well as Australia. No incentives were provided to participate in the poll, conducted March 25-27, according to Sermo.

 

Hydroxychloroquine usage was most widespread in Spain, where 72% of physicians surveyed said they had prescribed it, followed by Italy at 49%, and least popular in Japan, where 7% had used it to treat COVID-19.

 

The poll found 23% of U.S. medical professionals had prescribed the drug, which has been FDA-approved for malaria, lupus and rheumatoid arthritis.

Quoting Sermo CEO Peter Kirk [ which would be direct  counter to Dr. Bright’s insistence that these medications be only provided to hospitalized patients] “Physicians should have more of a voice in how we deal with this pandemic and be able to quickly share information with one another and the world,” he said. “With censorship of the media and the medical community in some countries, along with biased and poorly designed studies, solutions to the pandemic are being delayed.”

 

o. Dr. David Nazarian,  Beverly Hills-based physician, diplomate at the American Board of Internal Medicine and founder of My Concierge MD: "If you look [at the] countries where malaria is more prevalent and countries where COVID-19 infections are prevalent, you will find a striking difference. This correlation needs to be explored further as this is not just a mere coincidence,” 

https://www.youtube.com/watchv=mV3urNCQOKM&feature=emb_logo   Saturday, August 1, 2020    THIS VIDEO WAS REMOVED BY YOU TUBE 

 

 B   IVERMECTIN

 

Ivermectin 'Amazingly Successful' in Killing Coronavirus   By Tauren Dyson   August 9, 2020

 

An Australian drug known as Ivermectin, which is already in use throughout the world to treat parasitic conditions, is showing great results in killing coronavirus in studies involving patients, according to Sky News.

 

"Because I'm involved in developing these in the U.S. where all the patients are, there are a number of studies that are amazingly successful. We're talking close to 100%. In fact, we haven't seen a result yet under 100%. It looks like corona is very simple to kill,"  Professor Thomas Brody, medical director of Australia's Center for Digestive Disease. "It's available as a prescription medication. You wouldn't use it alone ... but you add two other things to it such as doxycycline and zinc."

 

Ivermectin is already approved by the FDA and is on the World Health Organization's list of model list of essential medicines.

 

"We had a 14-hospital trial in Bangladesh. We got [cured] 100 out of 100. In China, they tried to reproduce it. They got 60 out of 60 cured ... So I am behind the Ivermectin, doxycycline, zinc treatment because it has very few side effects and is a real killer of coronavirus," Borody said.

 

Borody said the Ivermectin tablet could cost as little as $2.

 

About Professor Thomas Borody.  Professor Borody is most famous for his ground-breaking work developing the triple therapy cure for peptic ulcers in 1987, which has saved hundreds of thousands of lives, and the Australian health system more than $10 billion in medical care and operations.Professor Borody founded the Centre for Digestive Diseases (CDD) in 1984 after a distinguished career with leading hospitals including St Vincent’s in Sydney and the Mayo Clinic in the USA.He is a world-renowned leader in the clinical microbiota dating back to 1988 when he started performing what is now called Fecal Microbiota Transplantation (FMT). In addition, Dr. Borody has established novel therapies in the gastrointestinal field, including areas such as inflammatory bowel disease, irritable bowel syndrome, CDI, parasite infestation, and resistant Helicobacter pylori via a bismuth-based ‘Triple Therapy’.

 

 

 

 9. CLOSING GENERAL OBSERVATION  The single most effective way to save lives would be to improve infection control in nursing homes.

 

 Providing adequate sanitation and medical care in nursing homes should markedly reduce the covid-19  death rate.   And regarding sanitation procedures ,there is a lot for our nursing home administrators and politicians to learn.  An excellent source for standards and practices would be the operations of America’s pig farmers (I’m not kidding,…. read  the careful procedures that America's pig farmers follow to prevent the spread of infections in their pig breeding facilities.)]

 

On Thursday, November 26, 2020, 06:38:19 PM PST, H Laitin wrote: Begin forwarded message: From: H Laitin Subject: TO EMILY...... FOR HELP Date: November 26, 2020 at 6:33:50 PM PST To: Emily Laitin Cc: howard laitin 1. The original text that I want to copy into a blog Hydroxychloroquine.... the debate... First I would like to introduce myself so that you can evaluate my experience, education, affiliations etc. Attachment one is a series of write-ups prepared by the Department of Defense, the state of California, the U.S. Army, the Department of Health and Human Services, etc. in conjunction with my scientific advisory activities with multiple US government, state of California, Los Angeles County and nonprofit advisory organizations such as RAND Corporation, the center for strategic International studies, etc. The second attachment is a link to a Senate hearing. By way of disclosure, One of the witnesses in favor of the early treatment use of hydroxychloroquine is from Baylor medical school. I taught at Baylor University when I was stationed at the U.S. Army medical school. The Third attachment is a multilayered program including airflow management; rapid inexpensive testing; prophylactic treatment; early therapy. ATTACHMENT ONE: 1.From US Department of Defense : Howard Laitin Torrance : California : United States Harvard, Ph.D.(Economics; Public Health). National Defense University Graduate Program; U.S. Army Command and General Staff College; Career Officer Course; Lt. Col. USA (Retired). Chief Scientist, Hughes Aircraft Company & Raytheon Corporation (Retired). Adjunct Professor of Engineering, USC. Clinical Associate Professor of Public Health, UCLA. Registered Professional Engineer (California). US Military Advisory Groups to: Egypt, Jordan, Saudi Arabia; Iranian Nuclear Program: Review of technology and sustainable development. Iraqi Intervention: Review of alternatives and probable outcomes. Consultant/Advisor: Center for Strategic and International Studies; Hudson Institute; Institute for Defense Analyses; Rand Corporation; Government Accountability Office; Office of Management and Budget; Department of Defense; Department of Health and Human Services; Department of Transportation; US Treasury. Army Science Board,; . National Highway and Traffic Safety Administration; National Science Foundation; US Customs Service; US Public Health Service. Chairman Environmental Quality Programs: Governor Ronald Reagan, Governor Jerry Brown. 2. From the state of California Howard Laitin, Record of Service - Partial I. General A. Harvard, Ph.D.(Economics Public Health). B. Lt. Col. USAR (Retired). Enlisted Service through rank of SFC; commissioned service through rank of Lt. Col. C. Chief Scientist, Hughes Aircraft, (Retired) D. Adjunct Professor of Engineering, University of Southern California E. Clinical Associate Professor of Public Health, University of California, Los Angeles. F. Registered Professional Engineer (California) II. Intelligence/Military Operations(Consultant/Advisor) A. Center for Strategic and International Studies (CSIS) B. Hudson Institute C. Institute for Defense Analyses (IDA) D. Rand Corporation III. Policy Development and Evaluation(Consultant/Advisor) A. Government Accountability Office (GAO) B. Office of Management and Budget (OMB) C. Dept. of Defense, Office of Secretary D. Dept. of Health and Human Services, Office of the Secretary E. Dept. of Transportation, Office of the Secretary F. US Treasury, Office of Secretary G. Army Science Board, Member H. National Highway and Traffic Safety Administration I. National Science Foundation J. US Customs Service K. US Public Health Service IV. Review of program and policy alternatives (Advisor/Reviewer) A. Iranian Nuclear Program (until 8/04): With professor Najm Meshkati. Review of reports (prepared by Iran’s Center for Strategic Research (CSR); Ministry of Foreign Affairs; Atomic Energy Organization; Ministry of Science, Research and Technology, etc.) on such topics as nuclear technology and sustainable development, Iran’s nuclear fuel cycle program, etc., to be presented at various Iranian organized international meetings. B. Iraqi Intervention: With Stan Katten (Rand Alumni and Policy Forum). In-depth study and evaluation of the alternative responses and courses of action regarding the Iraq threat that had been available to the United States (President George W. Bush) at the beginning of 2003 and an assessment, for each, of their probable outcomes. C. Military Assistance Programs 1. US Military Advisory Group to the Government of Egypt 2. US Military Advisory Group to the Government of Jordan 3. US Military Advisory Group to the Government of Saudi Arabia (National Guard) V. Development of Environmental Quality Programs (Chaired Councils and Working Groups) A. Board of Supervisors, Los Angeles County (public member of several boards) B. State of California 1. Gov. Ronald Reagan (Chaired Task Forces, Committees and Councils) 2. Gov. Jerry Brown (Chaired Task Forces, Committees and Councils) 3. Assembly Science and Technology Committee 3.Office of the Surgeon General, U.S. Army unknown.jpg 4. page 1 of three; US Department of Health and Human Services unknown.png 5. from the legal departments of General Motors, Raytheon, Hughes Aircraft had three major Washington DC law firms. HOWARD LAITIN SUPPORT TO HUGHES AND GM LEGAL 1986-1992] 1992 • Supported GM Legal on a very significant patent infringement case. Thoroughly explored and documented the state-of-the-art [prior to 1957] for a wide range of relevant technologies. — Conducted 350+ interviews with leading university, government and industry scientists. — Conducted thorough search of the technical literature. Screened several thousand technical articles and reports. Located 400+ potentially relevant articles for further evaluation. Prepared 25+ summary evaluation reports for GM and their law firms. • Supported Corporate and RSG Legal on current civil litigation [for both Hughes claims and Hughes counter-claims]. — Helped screen and evaluate a large mass of technical and program planning materials that had been obtained by Hughes and by Kirkland and Ellis as a result of discovery actions. 1991 • Supported Corporate Legal and MSG Legal in successfully refuting allegations of defective pricing and failure to disclose. — Analyzed and helped document the appropriateness of the pricing strategy that MSG had utilized on the bids that had been questioned. — Researched and documented the availability of "open sources" for certain Government and competitor information that had been located in MSG files. Prepared a matrix showing the multiple possible prior public sources for all of the information that had been questioned. 1990 • Supported Corporate Legal and King and Spalding in successfully refuting allegations concerning the misuse of classified budget information by senior Hughes executives. Through a very extensive search, replicated, from "available open sources," the documents and the specific data that had been questioned. Obtained a signed statement from DoD legal confirming the availability of the questioned data in a specific DoD data bank and affirming that the former MSG Executive had both the required security clearance and the required need-to-know to request the data, and that upon his request, the former MSG Executive would have been granted access to this data. • Supported GM Legal in locating and obtaining qualified Hughes Aircraft technical support for the successful determination that the Allison Gas Turbine engines were not the cause of the Piper Alpha drilling platform disaster. — Conducted comprehensive (confidential) company-wide technical resource search to identify and qualify extremely skilled photo enhancement and photo analysis specialists (and the necessary r hardware and programming resources]. — Worked with a GM contractor [Failure Analysis, Inc.] to validate a model which helped document the point of origin and the direction of the flow of the fire. 1988 • At the request of John Kuelbs [who responded to the request of Donald Atwood], recruited a small team that successfully worked with Delco Systems Operations and the U.S. Government to rescind the Government's Contractor System Status Review decision which made DSO ineligible for the award of any additional U.S. Government contracts. Met with DSO and Government personnel and surveyed DSO's operations and files to identify significant problems and their basic causes. — Helped prepare summary reports outlining the problems and proposing a definitive "get-well plan." — Helped obtain Government and DSO acceptance of the plan. — Assisted on the implementation activities which successfully reversed the Government's original decision. • Later, in response to a request from Dr. Currie, provided "very substantial assistance" to Bob Roderick in preparing a thorough assessment of the technical and market status of DSO's various product lines. • Organized Army-mandated Govenment/Industry Advisory Review Panel which worked with the Hughes C-NITE Program Office and with AVSCOM to develop an acceptable [to the Government and to Hughes], technically feasible, cost-effective corrective action plan which would improve to the point of acceptance the then unacceptable C-NITE EMI conditions. These conditions constituted "a very critical technical lean" which threatened the possible assessment of damages against Hughes Aircraft • At the request of GM Corporate Environmental Activities Staff, helped GM find and qualify an expert consulting company to locate and remediate the effects of hazardous waste leaks from several hundred underground storage tanks. • Organized the EDSG portion of the technical program for the visit of the Howard Hughes Medical Institute Board to Hughes. • Evaluated BFVS warranty clause impacts. Recommended changes. — Reviewed the Program's technical and performance data and developed estimates of possible impacts of the then current contract an plan. — Constructed a computer model for detailed analysis and evaluation of alternatives. Made recommendations to EDSG Legal and Contracts and to the HAC BFVS Program Office. 1986 • In support of EDSG Legal and M-l Contracts, supported the M-l claims [successfully settled for approximately $2.5M]. — Helped determine the specific causes of action and potential strategies. — Helped document the basic facts and supporting detail. [50% ofthe cost analysis documentation; 80% of the historical information documentation; and 75% of the participant interviewing documentation.] — Identified a legal precedent which required the Government to "start the clock" moving for paying interest to Hughes on the claim. • Supported the visit of the GM Board of Directors to Hughes. • Participated in developing the BFVS Corrective Action Plan for the U.S. Army. — Developed a computerized through-put model to estimate BFVS deliveries in response to various proposed program actions. Analyzed the financial impacts and expected schedule results of various alternative "get well" approaches. Worked with BFVS Contracts on developing appropriate clauses and supporting data for the contract negotiations. Assisted BFVS Contracts by participating in the Government's "fact finding" visits. • Worked with EDSG Legal on developing the strategy and the detailed submissions which successfully countered the potential $6M claim against Hughes on the M-60 Economic Escalation Clause. Developed the fundamental approach, structured the formula, and directed the required computational efforts. Worked with M-60 Contracts on both preparing and making the presentations to the MICOM Contracts Office which resulted in their favorable decision. 6. And finally read Gen Colin Powell’s view MY AMERICAN JOURNEY by Colin Powell [Chapt 7- White House Fellow] Fred Malek, Joe Laitin, and Velma Baldwin were my mentors. In all the schools of political science, in all the courses in public administration throughout the country, there could be nothing comparable to this education. I knew where I wanted to spend my year as a White House Fellow—at an agency whose very name would cause most eyelids to droop, OMB, the Office of Management and Budget. I knew from my MBA courses and my time in the Pentagon that budgets are to organizations what blood is to the circulatory system. And OMB had its hand on every department's jugular. It is one of the least understood yet most powerful federal agencies in Washington. ATTACHMENT TWO: Recent Senate hearing. I will stake my lifelong professional reputation on Prof. Harvey Risch being 100% correct. https://www.youtube.com/watch?v=ftq6lmRlKgQ&feature=emb_logo ATTACHMENT THREE: Multilayered program to safely reopen the US society and the US economy. Subject: RESTORING AMERICA’S ROBUST, ECONOMIC, EDUCATIONAL, SOCIAL, RELIGIOUS, AND OTHER COMMUNAL ACTIVITIES I believe that all the elements are present to fully reopen all schools, churches, synagogues mosques, offices, industrial activities, commercial activities, social and athletic activities, etc. I would like to propose what I believe would be a safe, effective and economical program which will give the the entire American population more assurance of health and safety than do the current pandemic lockdown mandates. Howard Laitin 4916 White Court Torrance CA 90503-2245 hlaitin@gmail.com message phone + fax 310-370-5011 1. There are simple, inexpensive procedures that would guarantee safety at a level much higher than that which is claimed for the current NY and California lockdown mandates’. 2. I am attaching an introductory memo which should give individual entities the ability to proceed with the specifics that are tailored to the individual needs of their communities. Also, contained in this memo are first cut leads, who should then be able to connect each of the various entities with specific advisors that COULD help them develop their individualized programs. Again note , what is provided is information and links to qualified individuals who could then provide the necessary information for each organization and community to develop their own program. 3. Basically, I am recommending: a. All classrooms, offices, etc. be equipped with air scrubbers and other ventilation and air purification techniques to make the indoors circulation and air purity at least as robust as the outdoor circulation currently is;There is an abundance of available information on the use of fans, etc. to increase indoor air circulation. There is an increasing amount of information being released about systems utilizing ultraviolet, ozone, etc. to kill the airborne virus]. Also, all surfaces will be wiped down every day with a treatment that has already been approved by the US EPA (which is certified to kill the coronavirus for at least one week). b.prophylactic use of hydroxychloroquine; c.Inexpensive, rapid, easy to read tests which could be self-administered to shoppers, students, religious worshipers, commercial and service workers, etc. who after five to 15 minutes would then be shown to be noninfectious and thus not subject to masking or social distancing requirements. d. Prompt and effective out-patient treatment to those who’re shown to infected [ rather than having them wait at home to see what happens to them in terms their developing significant symptoms [and the resulting medical complications and disabilities] ,which is the current standard medical practice. [Should any participant(s) present with any symptoms of the virus, then they, their family members and others in very close contact with them should be placed immediately in a treatment program. I would suggest that if the patient was on hydroxychloroquine as a prophylactic then he should be switched to Ivermectin as a therapeutic.] . 4. Benefits for the community a. Substantially reduces the likelihood of transmission of the virus; b. Provides protection for the most vulnerable [the aged, those with one or more existing medical conditions such as obesity, diabetes, heart problems, etc.]; c. Provides prophylactic protection for those who may become exposed to the virus ….and if already exposed to the virus, provides the early" fire extinguisher" type of protection against the increasing buildup of the patient's viral load. d. At a minimum the community will achieve substantially reduced infection rates probably similar to those Third World countries which routinely utilize hydroxychloroquine as an over-the-counter prophylactic against yellow fever. Data shows that Covid-19 infection rates in those countries has been far below that the infection rates of Europe, the United States, China etc. e If it works as well as it has reported in various peer-reviewed cited studies, then lockdowns, social distancing, masks, and other restrictions on community life will have been proved to be unnecessary and the community will be able to emerge from its current social and economic Covid-19 quagmirereturn and return to its robust pre-pandemic life. 5. Costs a. Medically hydroxychloroquine;has been in use for decades both as a prophylactic and in certain conditions such as lupus and experience shows that is safe no medical consequences] The drug is a generic. It is low cost. Many dozens, possibly hundreds of drug manufacturers now manufacturing supplements, could easily manufacture this drug in quantity at low cost and meet the highest standards of purity. 6. BACKGROUND READING & LINKS a. Dr. Harvey Risch of the Yale School of Public Health [harvey.risch@yale.edu ….”The Key to Defeating COVID-19 Already Exists[ hydroxychloroquine]. We Need to Start Using It “…..] b. How to Beat COVID-19 with Daily Quick Tests At Home: Summary by Dr. Mina. Date: August 30, 2020 https://youtu.be/AZWuyvBAWWQ c. I recommend that you listen to the entire video …. approximately one hour, 24 minutes. In this video 9 licensed and practicing physicians discuss their treatment experience. [ The interviewer is Charlie Kirk. Link one is YouTube, but since it might be taken down, here is Link two ( ISRAPUNDIT.)] https://www.youtube.com/watch?v=nn2P4-cK_K8&feature=youtu.be https://www.israpundit.org/the-charlie-kirk-show-nine-doctors-speak-out/ d.. Video : “ Why Lupus Patients May Hold The Key To Whether Hydroxychloroquine Could Work" - link : Why Lupus Patients May Hold The Key To Whether Hydroxychloroquine Could Work – Part 2 https://www.doctoroz.com/episode/covid-19-pandemic-why-lupus-patients-may-hold-key-whether-hydroxychloroquine-could-work-keep?video_id=6147739736001 https://www.doctoroz.com/episode/covid-19-pandemic-why-lupus-patients-may-hold-key-whether-hydroxychloroquine-could-work-keep 7. TESTING INFORMATION TESTING people, who carry the coronavirus whether they have obvious signs of infection or do not have obvious signs of infection, will test positive before they become carriers on numerous rapid tests that are nearly immediately available. you should do your own evaluation and not depend upon prior United States approval . Dr Mina explains why the existing structure and charters responsibility of the various existing US government medical institutions make them a roadblock and not functioning highway. Subject: How to Beat COVID-19 with Daily Quick Tests At Home: Summary by Dr. Mina. Date: August 30, 2020 https://youtu.be/AZWuyvBAWWQ unknown_1.png unknown_2.png Thus give each person [ either periodically or on their way into the classroom, service, restaurant, game/event, transportation, office, store, etc] a simple, inexpensive screening test that can be immediately read by anyone, without any special laboratory equipment. To get there, it is necessary to recognize the major difference between diagnostic tests – which can detect ultra-low levels of viral RNA – and public health screening tests, which tell you whether you are contagious. Diagnostics are what doctors use to know why someone is sick. They are a specific kind of test. A diagnostic that a doctor orders must be very good to do what it is meant to do – determine if someone is sick for a specific reason. So it needs to be high sensitivity and high specificity, there’s little wiggle room. A public health [surveillance] test indicates that something is present which warrants further examination and possible follow-up.[ The criticism of many of these tests is that they fail to detect a positive during the first several days of the infection as the virus count goes up but is still below the threshold of sensitivity. If the tests are administered once a week this should not matter since the person who is infected becomes a transmitter only after several days [? Check out and insert the correct exact range] and the second test a week later should read positive.] As background,view the following video download https://youtu.be/qKM4MIrfr4k it is an interview by Dr. Kyle Allred [cofounder of MEDCRAM a video educational site with Bobbi Brooke Herrera PhD, cofounder of e25 Bio. Dr Allred is a useful switchboard contact. This means he maintains a wide network and has an inkling of lots of things happening in lots of places. He can be reached at customers@medcram.com Dr Herrera can be reached at info@e25bio.com. He should be a good information source for the current status of simple screening test developments at a large number of firms. These two discussions should yield a lot of payoff in terms of useful contacts, information, etc. MedCram Update 98 for context on rapid daily quick tests and Dr. Mina's research | https://youtu.be/h7Sv_pS8MgQ 8. MEDICATION INFORMATION There are two well-established medications both of which have a long history of safe usage.[ A. Hydroxychloroquine; B Ivermectin] A. HYDROXYCHLOROQUINE a. Approximately one hour, 24 minutes. 10 licensed and practicing physicians discuss their treatment experience. [ The interviewer is Charlie Kirk. Link one is YouTube, but since it might be taken down, here is Link two ( ISRAPUNDIT.)] https://www.youtube.com/watch?v=nn2P4-cK_K8&feature=youtu.be https://www.israpundit.org/the-charlie-kirk-show-nine-doctors-speak-out/ b... Video : “ Why Lupus Patients May Hold The Key To Whether Hydroxychloroquine Could Work" - link : Why Lupus Patients May Hold The Key To Whether Hydroxychloroquine Could Work – Part 2 https://www.doctoroz.com/episode/covid-19-pandemic-why-lupus-patients-may-hold-key-whether-hydroxychloroquine-could-work-keep?video_id=6147739736001 c.. From HARVEY A. RISCH, MD, PHD , PROFESSOR OF EPIDEMIOLOGY, YALE SCHOOL OF PUBLIC HEALTH ….”The Key to Defeating COVID-19 Already Exists[ hydroxychloroquine]. We Need to Start Using It “ As professor of epidemiology at Yale School of Public Health, I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals. I am usually accustomed to advocating for positions within the mainstream of medicine, so have been flummoxed to find that, in the midst of a crisis, I am fighting for a treatment that the data fully support but which, for reasons having nothing to do with a correct understanding of the science, has been pushed to the sidelines. As a result, tens of thousands of patients with COVID-19 are dying unnecessarily. Fortunately, the situation can be reversed easily and quickly.I am referring, of course, to the medication hydroxychloroquine. When this inexpensive oral medication is given very early in the course of illness, before the virus has had time to multiply beyond control, it has shown to be highly effective, especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc. On May 27, I published an article in the American Journal of Epidemiology (AJE) entitled, “Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis.” That article, published in the world’s leading epidemiology journal, analyzed five studies, demonstrating clear-cut and significant benefits to treated patients, plus other very large studies that showed the medication safety d. Hydroxy Hysteria Reaching a Fever Pitch [Exerpts] By Brian C. Joondeph, M.D. American Thinker 7-31-20 Ever since President Trump mentioned hydroxy as a possible therapeutic, the media have castigated it as worse than rat poison. They’ve criticized any use of it in a constant barrage of fear, telling everyone that this 60-year-old drug would kill anyone who dared tak 8-e it. Hydroxy was FDA-approved in 1955 and is taken for lupus and rheumatoid arthritis. FDA approval means the approved drug is both efficacious and safe. All of a sudden, after 60 years, the FDA decided hydroxy is no longer safe because of, “serious heart rhythm problems and other safety issues, including blood and lymph system disorders, kidney injuries, and liver problems and failure.” If it is so unsafe, why did the FDA not rescind its 60-year-old approval? It is worth noting that diseases treated by hydroxy for the past half century can cause these problems as well. As can COVID, which if severe, can also cause death. So, the FDA deems it safe to treat those sick with lupus and autoimmune diseases with hydroxy but not those sick or hospitalized with COVID.Several days ago, a group of physicians called “America’s Frontline Doctors held a press conference in front of the U.S. Supreme Court building discussing the coronavirus and hydroxychloroquine. One physician in particular, Dr Stella Immanuel, gave an impassioned shout-out for hydroxy: I have personally treated over 350 patients with COVID. Patients that have diabetes, patients that have high blood pressure, patients that have asthma, old people … I think my oldest patient is 92 … 87-year old. And the result has been the same. I put them on hydroxychloroquine, I put them on zinc, I put them on Zithromax, and they’re all well. . Some studies say hydroxy doesn’t work, like giving hydroxy to patients too sick to benefit, already on a ventilator, as in the VA study. Other studies found safety concerns and were published in prestigious medical journals like The Lancet and The New England Journal of Medicine, only to be discovered to be bogus and retracted. Still other studies, as from the Henry Ford Health System noted that hydroxy cut the death rate in half. This chart from the Association of American Physicians and Surgeons shows a much lower case fatality rate in countries where hydroxy is allowed and encouraged rather than banned or discouraged. e.Hydroxychloroquine by Emily Benedek The Tablet 8-14-20 https://www.tabletmag.com/sections/science/articles/hydroxychloroquine-morality-tale Early in the coronavirus pandemic, a survey of the world’s frontline physicians showed hydroxychloroquine to be the drug they considered the most effective at treating COVID-19 patients. That was in early April, shortly after a French study showed it was safe and effective in lowering the virus count, at times in combination with azithromycin. Next we were told hydroxychloroquine was likely ineffective, and also dangerous, and that that French study was flawed and the scientist behind it worthy of mockery. More studies followed, with contradictory results, and then out came what was hailed by some as a definitive study of 96,000 patients showing the drug was most certainly dangerous and ineffective, and indeed that it killed 30% more people than those who didn’t take it. Within days, that study was retracted, with the editor of one of the two most respected medical journals in the Western world conceding it was “a monumental fraud.” And on it went. f.Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows July 02, 2020 https://www.henryford.com/news/2020/07/hydro-treatment-study DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new studypublished by Henry Ford Health System. In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020 across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19. The study was published today in the International Journal of Infectious Diseases, the peer-reviewed, open-access online publication of the International Society of Infectious Diseases (ISID.org). Patients treated with hydroxychloroquine at Henry Ford met specific protocol criteria as outlined by the hospital system’s Division of Infectious Diseases. The vast majority received the drug soon after admission; 82% within 24 hours and 91% within 48 hours of admission. All patients in the study were 18 or over with a median age of 64 years; 51% were men and 56% African American. “The findings have been highly analyzed and peer-reviewed,” said Dr. Marcus Zervos, division head of Infectious Disease for Henry Ford Health System, who co-authored the study with Henry Ford epidemiologist Samia Arshad. “We attribute our findings that differ from other studies to early treatment, and part of a combination of interventions that were done in supportive care of patients, including careful cardiac monitoring. Our dosing also differed from other studies not showing a benefit of the drug. And other studies are either not peer reviewed, have limited numbers of patients, different patient populations or other differences from our patients.” Zervos said the potential for a surge in the fall or sooner, and infections continuing worldwide, show an urgency to identifying inexpensive and effective therapies and preventions. “We’re glad to add to the scientific knowledge base on the role and how best to use therapies as we work around the world to provide insight,” he said. “Considered in the context of current studies on the use of hydroxychloroquine for COVID-19, our results suggest that the drug may have an important role to play in reducing COVID-19 mortality.” The study also found those treated with azithromycin alone or a combination of hydroxychloroquine and azithromycin also fared slightly better than those not treated with the drugs, according to the Henry Ford data. The analysis found 22.4% of those treated only with azithromycin died, and 20.1% treated with a combination of azithromycin and hydroxychloroquine died, compared to 26.4% of patients dying who were not treated with either medication. “Our analysis shows that using hydroxychloroquine helped save lives,” said neurosurgeon Dr. Steven Kalkanis, CEO, Henry Ford Medical Group and Senior Vice President and Chief Academic Officer of Henry Ford Health System. “As doctors and scientists, we look to the data for insight. And the data here is clear that there was benefit to using the drug as a treatment for sick, hospitalized patients.” Henry Ford Health System, as one of the region’s major academic medical centers with more than $100 million in annual research funding, is involved in numerous COVID-19 trials with national and international partners. Henry Ford Health System is a $6.5 billion integrated health system comprised of six hospitals, a health plan, and 250+ sites including medical centers, walk-in and urgent care clinics, pharmacy, eye care facilities and other healthcare retail. Established in 1915 by auto industry pioneer Henry Ford, the health system now has 32,000 employees and remains home to the 1,900-member Henry Ford Medical Group, one of the nation’s oldest physician groups. An additional 2,200 physicians are also affiliated with the health system through the Henry Ford Physician Network. An active participant in medical education and training, the health system has trained nearly 40% of physicians currently practicing in the state and also provides education and training for other health professionals including nurses, pharmacists, radiology and respiratory technicians. g.. Concerning Hydroxychloroquine .Everyone that I deal with says the secret of success is early use… yet all the negative reports that I’ve seen are based on relatively late use h.. My oldest granddaughter and her entire team were on a prophylactic regime of Hydroxychloroquine during their assignment to Africa. No one suffered from any side effects. i.. Encino CA Harvard Medical School MD; board certified in internal medicine and other specialties; UCLA internship and residency and now on the clinical faculty of UCLA; clinic director; in private practice including infectious diseases for more than 30 years has successfully used Hydroxychloroquine with many patients.[ current data to be obtained.] He likens its use to a fire extinguisher and says it is effective very early in the game when symptoms first appear before the virus really gets a toe hold. [“So far in my clinical experience, I can tell you that Hydroxychloroquine/Azithromycin combo has been 100% effective for my CoV patients, when used in conjunction with all of the Integrative …. I employ. Needs to be given early enough in the course of the illness to be maximally effective. Much like a fire extinguisher can put out a small kitchen fire, but if a house is engulfed in flames, you need a fire hose. Doesn’t mean fire extinguishers don’t work for house fires, just need to be used early in the event……”] j. Phoenix AZ Tufts medical school MD; board-certified in anesthesiology and pain management; clinic manager tells me that all of his associates prescribe Hydroxychloroquine and would use it in their own families. k.. Torrance CA a local physician prescribed it to both of his elderly parents [ mother late 80s, father early 90s] who tested positive for Covid-19 just before both were taken to the hospital in serious condition. Although the expectations were that one or both would die-both survived and are now both well on the road to recovery. ironically, the mother was selected for a medical test but received the placebo. Otherwise except for Hydroxychloroquine she had no other medication. The physician at the hospital claimed that Hydroxychloroquine was ineffective. The son , in a major article ,claimed otherwise. If the report was to be utilized by CDC they would take the hospital position and chalk it up that it was “ineffective.” l. Coronavirus at Texas Nursing Home – Hydroxychloroquine Treatment Saves All But 1 Patient The Resort at Texas nursing home had an outbreak of coronavirus that infected 56 residents and 33 staff members. “Two of our residents had symptoms and that’s when we tested everybody,” said nursing home Executive Director Jan Piveral. 56 residents and 33 staff members were COVID-19 positive. “Our Goal was to make sure we could shelter them in place so we don’t spread it to other people,” Armstrong said. “Then also at the same time treat them so they would get better.”Dr. Robin Armstrong immediately administered hydroxychloroquine to the residents and staff members along with Zpac and Zinc. Only one nursing home patient died since the doctor prescribed the hydroxychloroquine. 55 made it. When Armstrong began administering Hydroxychloroquine to it was controversial but appeared promising.“If we didn’t make the decision quickly then we could potentially lose 15 to 20% of the residents which was not an option,” said the Doctor. Armstrong’s approach was to begin administering Hydroxychloroquine a Zpac and Zinc just as soon as a resident first started showing symptoms.The patients were being monitored daily. “We did EKGs on each of these patients to make sure they didn’t have the cardiac side effects that everyone talks about,” Armstrong said. “None of our patients did.”Armstrong doesn’t call the Hydroxychloroquine a cure and is aware of all the recent reports that say the drug shouldn’t be used to treat COVID-19.But he points out only one of the nursing homes COVID-19 patients has died.“Everyone who got on treatment who started on treatment is actually doing really well,” he said. m. Information from Monroe, New York Since 3/15/20, my team has seen approximately 1354 patients in Monroe, New York with either test proven or clinically suspected coronavirus infection. The majority of the patients were treated with only supportive care. The patients with shortness of breath or who are in the high risk category were treated with the above regimen (approximately 405 patients at this point).. Of this group and the information provided to me by affiliated medical teams, we have had two deaths, six hospitalizations for pneumonia, and four intubations (all extubated now). In addition, I have not heard of any negative side effects other than approximately 10% of patients with temporary nausea and diarrhea. In sum, my urgent recommendation is to initiate treatment in the outpatient setting as soon as possible in accordance with the above. Based on my direct experience, it prevents acute respiratory distress syndrome (ARDS), prevents the need for hospitalization and saves lives. Conclusion: TREAT AS EARLY AND AS AGGRESSIVELY AS POSSIBLE IN THE OUTPATIENT SETTING n. MORE THAN 2,304 PHYSICIANS WHO ARE CURRENTLY SUCCESSFULLY TREATING PATIENTS INFECTED WITH THE COVID-19 REPORTED THEIR “ANECDOTAL EVIDENCE” OF THEIR SUCCESS WITH THEIR PATIENTS UTILIZING HYDROXYCHLOROQUINE An international survey conducted by Sermo, a global health care polling company, of 6,227 physicians in 30 countries found that 37% of those treating COVID-19 patients rated hydroxychloroquine as the “most effective therapy” from a list of 15 options. The survey also found that the most commonly prescribed treatments are analgesics (56%), azithromycin (41%) and hydroxychloroquine (33%). Hydroxychloroquine, which is sold under the brand name Plaquenil, was prescribed mainly in the United States for the most severe cases, but not so in other countries. “Outside the U.S., hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the U.S. it was most commonly used for high risk diagnosed patients,” the survey found. The 30 nations surveyed included those in Europe, Asia, North America and South America, as well as Australia. No incentives were provided to participate in the poll, conducted March 25-27, according to Sermo. Hydroxychloroquine usage was most widespread in Spain, where 72% of physicians surveyed said they had prescribed it, followed by Italy at 49%, and least popular in Japan, where 7% had used it to treat COVID-19. The poll found 23% of U.S. medical professionals had prescribed the drug, which has been FDA-approved for malaria, lupus and rheumatoid arthritis. Quoting Sermo CEO Peter Kirk [ which would be direct counter to Dr. Bright’s insistence that these medications be only provided to hospitalized patients] “Physicians should have more of a voice in how we deal with this pandemic and be able to quickly share information with one another and the world,” he said. “With censorship of the media and the medical community in some countries, along with biased and poorly designed studies, solutions to the pandemic are being delayed.” o. Dr. David Nazarian, Beverly Hills-based physician, diplomate at the American Board of Internal Medicine and founder of My Concierge MD: "If you look [at the] countries where malaria is more prevalent and countries where COVID-19 infections are prevalent, you will find a striking difference. This correlation needs to be explored further as this is not just a mere coincidence,” https://www.youtube.com/watchv=mV3urNCQOKM&feature=emb_logo Saturday, August 1, 2020 THIS VIDEO WAS REMOVED BY YOU TUBE B IVERMECTIN Ivermectin 'Amazingly Successful' in Killing Coronavirus By Tauren Dyson August 9, 2020 An Australian drug known as Ivermectin, which is already in use throughout the world to treat parasitic conditions, is showing great results in killing coronavirus in studies involving patients, according to Sky News. "Because I'm involved in developing these in the U.S. where all the patients are, there are a number of studies that are amazingly successful. We're talking close to 100%. In fact, we haven't seen a result yet under 100%. It looks like corona is very simple to kill," Professor Thomas Brody, medical director of Australia's Center for Digestive Disease. "It's available as a prescription medication. You wouldn't use it alone ... but you add two other things to it such as doxycycline and zinc." Ivermectin is already approved by the FDA and is on the World Health Organization's list of model list of essential medicines. "We had a 14-hospital trial in Bangladesh. We got [cured] 100 out of 100. In China, they tried to reproduce it. They got 60 out of 60 cured ... So I am behind the Ivermectin, doxycycline, zinc treatment because it has very few side effects and is a real killer of coronavirus," Borody said. Borody said the Ivermectin tablet could cost as little as $2. About Professor Thomas Borody. Professor Borody is most famous for his ground-breaking work developing the triple therapy cure for peptic ulcers in 1987, which has saved hundreds of thousands of lives, and the Australian health system more than $10 billion in medical care and operations.Professor Borody founded the Centre for Digestive Diseases (CDD) in 1984 after a distinguished career with leading hospitals including St Vincent’s in Sydney and the Mayo Clinic in the USA.He is a world-renowned leader in the clinical microbiota dating back to 1988 when he started performing what is now called Fecal Microbiota Transplantation (FMT). In addition, Dr. Borody has established novel therapies in the gastrointestinal field, including areas such as inflammatory bowel disease, irritable bowel syndrome, CDI, parasite infestation, and resistant Helicobacter pylori via a bismuth-based ‘Triple Therapy’. 9. CLOSING GENERAL OBSERVATION The single most effective way to save lives would be to improve infection control in nursing homes. Providing adequate sanitation and medical care in nursing homes should markedly reduce the covid-19 death rate. And regarding sanitation procedures ,there is a lot for our nursing home administrators and politicians to learn. An excellent source for standards and practices would be the operations of America’s pig farmers (I’m not kidding,…. read the careful procedures that America's pig farmers follow to prevent the spread of infections in their pig breeding facilities.)] ****** 2. in the last week or so instead of following my paragraph format it has lumped the text into one mass. Also I have not been able transfer pictures to my blog but that may be due to my not knowing how to do it with a new format. Here is what it looks like on my blog https://ltgjcmilopsg3.blogspot.com/2020/11/hydroxychloroquine-debate.html Hydroxychloroquine.... the debate... First I would like to introduce myself so that you can evaluate my experience, education, affiliations etc. Attachment one is a series of write-ups prepared by the Department of Defense, the state of California, the U.S. Army, the Department of Health and Human Services, etc. in conjunction with my scientific advisory activities with multiple US government, state of California, Los Angeles County and nonprofit advisory organizations such as RAND Corporation, the center for strategic International studies, etc. The second attachment is a link to a Senate hearing. By way of disclosure, One of the witnesses in favor of the early treatment use of hydroxychloroquine is from Baylor medical school. I taught at Baylor University when I was stationed at the U.S. Army medical school. The Third attachment is a multilayered program including airflow management; rapid inexpensive testing; prophylactic treatment; early therapy. ATTACHMENT ONE: 1.From US Department of Defense : Howard Laitin Torrance : California : United States Harvard, Ph.D.(Economics; Public Health). National Defense University Graduate Program; U.S. Army Command and General Staff College; Career Officer Course; Lt. Col. USA (Retired). Chief Scientist, Hughes Aircraft Company & Raytheon Corporation (Retired). Adjunct Professor of Engineering, USC. Clinical Associate Professor of Public Health, UCLA. Registered Professional Engineer (California). US Military Advisory Groups to: Egypt, Jordan, Saudi Arabia; Iranian Nuclear Program: Review of technology and sustainable development. Iraqi Intervention: Review of alternatives and probable outcomes. Consultant/Advisor: Center for Strategic and International Studies; Hudson Institute; Institute for Defense Analyses; Rand Corporation; Government Accountability Office; Office of Management and Budget; Department of Defense; Department of Health and Human Services; Department of Transportation; US Treasury. Army Science Board,; . National Highway and Traffic Safety Administration; National Science Foundation; US Customs Service; US Public Health Service. Chairman Environmental Quality Programs: Governor Ronald Reagan, Governor Jerry Brown. 2. From the state of California Howard Laitin, Record of Service - Partial I. General A. Harvard, Ph.D.(Economics Public Health). B. Lt. Col. USAR (Retired). Enlisted Service through rank of SFC; commissioned service through rank of Lt. Col. C. Chief Scientist, Hughes Aircraft, (Retired) D. Adjunct Professor of Engineering, University of Southern California E. Clinical Associate Professor of Public Health, University of California, Los Angeles. F. Registered Professional Engineer (California) II. Intelligence/Military Operations(Consultant/Advisor) A. Center for Strategic and International Studies (CSIS) B. Hudson Institute C. Institute for Defense Analyses (IDA) D. Rand Corporation III. Policy Development and Evaluation(Consultant/Advisor) A. Government Accountability Office (GAO) B. Office of Management and Budget (OMB) C. Dept. of Defense, Office of Secretary D. Dept. of Health and Human Services, Office of the Secretary E. Dept. of Transportation, Office of the Secretary F. US Treasury, Office of Secretary G. Army Science Board, Member H. National Highway and Traffic Safety Administration I. National Science Foundation J. US Customs Service K. US Public Health Service IV. Review of program and policy alternatives (Advisor/Reviewer) A. Iranian Nuclear Program (until 8/04): With professor Najm Meshkati. Review of reports (prepared by Iran’s Center for Strategic Research (CSR); Ministry of Foreign Affairs; Atomic Energy Organization; Ministry of Science, Research and Technology, etc.) on such topics as nuclear technology and sustainable development, Iran’s nuclear fuel cycle program, etc., to be presented at various Iranian organized international meetings. B. Iraqi Intervention: With Stan Katten (Rand Alumni and Policy Forum). In-depth study and evaluation of the alternative responses and courses of action regarding the Iraq threat that had been available to the United States (President George W. Bush) at the beginning of 2003 and an assessment, for each, of their probable outcomes. C. Military Assistance Programs 1. US Military Advisory Group to the Government of Egypt 2. US Military Advisory Group to the Government of Jordan 3. US Military Advisory Group to the Government of Saudi Arabia (National Guard) V. Development of Environmental Quality Programs (Chaired Councils and Working Groups) A. Board of Supervisors, Los Angeles County (public member of several boards) B. State of California 1. Gov. Ronald Reagan (Chaired Task Forces, Committees and Councils) 2. Gov. Jerry Brown (Chaired Task Forces, Committees and Councils) 3. Assembly Science and Technology Committee 3.Office of the Surgeon General, U.S. Army 4. page 1 of three; US Department of Health and Human Services 5. from the legal departments of General Motors, Raytheon, Hughes Aircraft had three major Washington DC law firms. HOWARD LAITIN SUPPORT TO HUGHES AND GM LEGAL 1986-1992] 1992 • Supported GM Legal on a very significant patent infringement case. Thoroughly explored and documented the state-of-the-art [prior to 1957] for a wide range of relevant technologies. — Conducted 350+ interviews with leading university, government and industry scientists. — Conducted thorough search of the technical literature. Screened several thousand technical articles and reports. Located 400+ potentially relevant articles for further evaluation. Prepared 25+ summary evaluation reports for GM and their law firms. • Supported Corporate and RSG Legal on current civil litigation [for both Hughes claims and Hughes counter-claims]. — Helped screen and evaluate a large mass of technical and program planning materials that had been obtained by Hughes and by Kirkland and Ellis as a result of discovery actions. 1991 • Supported Corporate Legal and MSG Legal in successfully refuting allegations of defective pricing and failure to disclose. — Analyzed and helped document the appropriateness of the pricing strategy that MSG had utilized on the bids that had been questioned. — Researched and documented the availability of "open sources" for certain Government and competitor information that had been located in MSG files. Prepared a matrix showing the multiple possible prior public sources for all of the information that had been questioned. 1990 • Supported Corporate Legal and King and Spalding in successfully refuting allegations concerning the misuse of classified budget information by senior Hughes executives. Through a very extensive search, replicated, from "available open sources," the documents and the specific data that had been questioned. Obtained a signed statement from DoD legal confirming the availability of the questioned data in a specific DoD data bank and affirming that the former MSG Executive had both the required security clearance and the required need-to-know to request the data, and that upon his request, the former MSG Executive would have been granted access to this data. • Supported GM Legal in locating and obtaining qualified Hughes Aircraft technical support for the successful determination that the Allison Gas Turbine engines were not the cause of the Piper Alpha drilling platform disaster. — Conducted comprehensive (confidential) company-wide technical resource search to identify and qualify extremely skilled photo enhancement and photo analysis specialists (and the necessary r hardware and programming resources]. — Worked with a GM contractor [Failure Analysis, Inc.] to validate a model which helped document the point of origin and the direction of the flow of the fire. 1988 • At the request of John Kuelbs [who responded to the request of Donald Atwood], recruited a small team that successfully worked with Delco Systems Operations and the U.S. Government to rescind the Government's Contractor System Status Review decision which made DSO ineligible for the award of any additional U.S. Government contracts. Met with DSO and Government personnel and surveyed DSO's operations and files to identify significant problems and their basic causes. — Helped prepare summary reports outlining the problems and proposing a definitive "get-well plan." — Helped obtain Government and DSO acceptance of the plan. — Assisted on the implementation activities which successfully reversed the Government's original decision. • Later, in response to a request from Dr. Currie, provided "very substantial assistance" to Bob Roderick in preparing a thorough assessment of the technical and market status of DSO's various product lines. • Organized Army-mandated Govenment/Industry Advisory Review Panel which worked with the Hughes C-NITE Program Office and with AVSCOM to develop an acceptable [to the Government and to Hughes], technically feasible, cost-effective corrective action plan which would improve to the point of acceptance the then unacceptable C-NITE EMI conditions. These conditions constituted "a very critical technical lean" which threatened the possible assessment of damages against Hughes Aircraft • At the request of GM Corporate Environmental Activities Staff, helped GM find and qualify an expert consulting company to locate and remediate the effects of hazardous waste leaks from several hundred underground storage tanks. • Organized the EDSG portion of the technical program for the visit of the Howard Hughes Medical Institute Board to Hughes. • Evaluated BFVS warranty clause impacts. Recommended changes. — Reviewed the Program's technical and performance data and developed estimates of possible impacts of the then current contract an plan. — Constructed a computer model for detailed analysis and evaluation of alternatives. Made recommendations to EDSG Legal and Contracts and to the HAC BFVS Program Office. 1986 • In support of EDSG Legal and M-l Contracts, supported the M-l claims [successfully settled for approximately $2.5M]. — Helped determine the specific causes of action and potential strategies. — Helped document the basic facts and supporting detail. [50% ofthe cost analysis documentation; 80% of the historical information documentation; and 75% of the participant interviewing documentation.] — Identified a legal precedent which required the Government to "start the clock" moving for paying interest to Hughes on the claim. • Supported the visit of the GM Board of Directors to Hughes. • Participated in developing the BFVS Corrective Action Plan for the U.S. Army. — Developed a computerized through-put model to estimate BFVS deliveries in response to various proposed program actions. Analyzed the financial impacts and expected schedule results of various alternative "get well" approaches. Worked with BFVS Contracts on developing appropriate clauses and supporting data for the contract negotiations. Assisted BFVS Contracts by participating in the Government's "fact finding" visits. • Worked with EDSG Legal on developing the strategy and the detailed submissions which successfully countered the potential $6M claim against Hughes on the M-60 Economic Escalation Clause. Developed the fundamental approach, structured the formula, and directed the required computational efforts. Worked with M-60 Contracts on both preparing and making the presentations to the MICOM Contracts Office which resulted in their favorable decision. 6. And finally read Gen Colin Powell’s view MY AMERICAN JOURNEY by Colin Powell [Chapt 7- White House Fellow] Fred Malek, Joe Laitin, and Velma Baldwin were my mentors. In all the schools of political science, in all the courses in public administration throughout the country, there could be nothing comparable to this education. I knew where I wanted to spend my year as a White House Fellow—at an agency whose very name would cause most eyelids to droop, OMB, the Office of Management and Budget. I knew from my MBA courses and my time in the Pentagon that budgets are to organizations what blood is to the circulatory system. And OMB had its hand on every department's jugular. It is one of the least understood yet most powerful federal agencies in Washington. ATTACHMENT TWO: Recent Senate hearing. I will stake my lifelong professional reputation on Prof. Harvey Risch being 100% correct. https://www.youtube.com/watch?v=ftq6lmRlKgQ&feature=emb_logo ATTACHMENT THREE: Multilayered program to safely reopen the US society and the US economy. Subject: RESTORING AMERICA’S ROBUST, ECONOMIC, EDUCATIONAL, SOCIAL, RELIGIOUS, AND OTHER COMMUNAL ACTIVITIES I believe that all the elements are present to fully reopen all schools, churches, synagogues mosques, offices, industrial activities, commercial activities, social and athletic activities, etc. I would like to propose what I believe would be a safe, effective and economical program which will give the the entire American population more assurance of health and safety than do the current pandemic lockdown mandates. Howard Laitin 4916 White Court Torrance CA 90503-2245 hlaitin@gmail.com message phone + fax 310-370-5011 1. There are simple, inexpensive procedures that would guarantee safety at a level much higher than that which is claimed for the current NY and California lockdown mandates’. 2. I am attaching an introductory memo which should give individual entities the ability to proceed with the specifics that are tailored to the individual needs of their communities. Also, contained in this memo are first cut leads, who should then be able to connect each of the various entities with specific advisors that COULD help them develop their individualized programs. Again note , what is provided is information and links to qualified individuals who could then provide the necessary information for each organization and community to develop their own program. 3. Basically, I am recommending: a. All classrooms, offices, etc. be equipped with air scrubbers and other ventilation and air purification techniques to make the indoors circulation and air purity at least as robust as the outdoor circulation currently is;There is an abundance of available information on the use of fans, etc. to increase indoor air circulation. There is an increasing amount of information being released about systems utilizing ultraviolet, ozone, etc. to kill the airborne virus]. Also, all surfaces will be wiped down every day with a treatment that has already been approved by the US EPA (which is certified to kill the coronavirus for at least one week). b.prophylactic use of hydroxychloroquine; c.Inexpensive, rapid, easy to read tests which could be self-administered to shoppers, students, religious worshipers, commercial and service workers, etc. who after five to 15 minutes would then be shown to be noninfectious and thus not subject to masking or social distancing requirements. d. Prompt and effective out-patient treatment to those who’re shown to infected [ rather than having them wait at home to see what happens to them in terms their developing significant symptoms [and the resulting medical complications and disabilities] ,which is the current standard medical practice. [Should any participant(s) present with any symptoms of the virus, then they, their family members and others in very close contact with them should be placed immediately in a treatment program. I would suggest that if the patient was on hydroxychloroquine as a prophylactic then he should be switched to Ivermectin as a therapeutic.] . 4. Benefits for the community a. Substantially reduces the likelihood of transmission of the virus; b. Provides protection for the most vulnerable [the aged, those with one or more existing medical conditions such as obesity, diabetes, heart problems, etc.]; c. Provides prophylactic protection for those who may become exposed to the virus ….and if already exposed to the virus, provides the early" fire extinguisher" type of protection against the increasing buildup of the patient's viral load. d. At a minimum the community will achieve substantially reduced infection rates probably similar to those Third World countries which routinely utilize hydroxychloroquine as an over-the-counter prophylactic against yellow fever. Data shows that Covid-19 infection rates in those countries has been far below that the infection rates of Europe, the United States, China etc. e If it works as well as it has reported in various peer-reviewed cited studies, then lockdowns, social distancing, masks, and other restrictions on community life will have been proved to be unnecessary and the community will be able to emerge from its current social and economic Covid-19 quagmirereturn and return to its robust pre-pandemic life. 5. Costs a. Medically hydroxychloroquine;has been in use for decades both as a prophylactic and in certain conditions such as lupus and experience shows that is safe no medical consequences] The drug is a generic. It is low cost. Many dozens, possibly hundreds of drug manufacturers now manufacturing supplements, could easily manufacture this drug in quantity at low cost and meet the highest standards of purity. 6. BACKGROUND READING & LINKS a. Dr. Harvey Risch of the Yale School of Public Health [harvey.risch@yale.edu ….”The Key to Defeating COVID-19 Already Exists[ hydroxychloroquine]. We Need to Start Using It “…..] b. How to Beat COVID-19 with Daily Quick Tests At Home: Summary by Dr. Mina. Date: August 30, 2020 https://youtu.be/AZWuyvBAWWQ c. I recommend that you listen to the entire video …. approximately one hour, 24 minutes. In this video 9 licensed and practicing physicians discuss their treatment experience. [ The interviewer is Charlie Kirk. Link one is YouTube, but since it might be taken down, here is Link two ( ISRAPUNDIT.)] https://www.youtube.com/watch?v=nn2P4-cK_K8&feature=youtu.be https://www.israpundit.org/the-charlie-kirk-show-nine-doctors-speak-out/ d.. Video : “ Why Lupus Patients May Hold The Key To Whether Hydroxychloroquine Could Work" - link : Why Lupus Patients May Hold The Key To Whether Hydroxychloroquine Could Work – Part 2 https://www.doctoroz.com/episode/covid-19-pandemic-why-lupus-patients-may-hold-key-whether-hydroxychloroquine-could-work-keep?video_id=6147739736001 https://www.doctoroz.com/episode/covid-19-pandemic-why-lupus-patients-may-hold-key-whether-hydroxychloroquine-could-work-keep 7. TESTING INFORMATION TESTING people, who carry the coronavirus whether they have obvious signs of infection or do not have obvious signs of infection, will test positive before they become carriers on numerous rapid tests that are nearly immediately available. you should do your own evaluation and not depend upon prior United States approval . Dr Mina explains why the existing structure and charters responsibility of the various existing US government medical institutions make them a roadblock and not functioning highway. Subject: How to Beat COVID-19 with Daily Quick Tests At Home: Summary by Dr. Mina. Date: August 30, 2020 https://youtu.be/AZWuyvBAWWQ Thus give each person [ either periodically or on their way into the classroom, service, restaurant, game/event, transportation, office, store, etc] a simple, inexpensive screening test that can be immediately read by anyone, without any special laboratory equipment. To get there, it is necessary to recognize the major difference between diagnostic tests – which can detect ultra-low levels of viral RNA – and public health screening tests, which tell you whether you are contagious. Diagnostics are what doctors use to know why someone is sick. They are a specific kind of test. A diagnostic that a doctor orders must be very good to do what it is meant to do – determine if someone is sick for a specific reason. So it needs to be high sensitivity and high specificity, there’s little wiggle room. A public health [surveillance] test indicates that something is present which warrants further examination and possible follow-up.[ The criticism of many of these tests is that they fail to detect a positive during the first several days of the infection as the virus count goes up but is still below the threshold of sensitivity. If the tests are administered once a week this should not matter since the person who is infected becomes a transmitter only after several days [? Check out and insert the correct exact range] and the second test a week later should read positive.] As background,view the following video download https://youtu.be/qKM4MIrfr4k it is an interview by Dr. Kyle Allred [cofounder of MEDCRAM a video educational site with Bobbi Brooke Herrera PhD, cofounder of e25 Bio. Dr Allred is a useful switchboard contact. This means he maintains a wide network and has an inkling of lots of things happening in lots of places. He can be reached at customers@medcram.com Dr Herrera can be reached at info@e25bio.com. He should be a good information source for the current status of simple screening test developments at a large number of firms. These two discussions should yield a lot of payoff in terms of useful contacts, information, etc. MedCram Update 98 for context on rapid daily quick tests and Dr. Mina's research | https://youtu.be/h7Sv_pS8MgQ 8. MEDICATION INFORMATION There are two well-established medications both of which have a long history of safe usage.[ A. Hydroxychloroquine; B Ivermectin] A. HYDROXYCHLOROQUINE a. Approximately one hour, 24 minutes. 10 licensed and practicing physicians discuss their treatment experience. [ The interviewer is Charlie Kirk. Link one is YouTube, but since it might be taken down, here is Link two ( ISRAPUNDIT.)] https://www.youtube.com/watch?v=nn2P4-cK_K8&feature=youtu.be https://www.israpundit.org/the-charlie-kirk-show-nine-doctors-speak-out/ b... Video : “ Why Lupus Patients May Hold The Key To Whether Hydroxychloroquine Could Work" - link : Why Lupus Patients May Hold The Key To Whether Hydroxychloroquine Could Work – Part 2 https://www.doctoroz.com/episode/covid-19-pandemic-why-lupus-patients-may-hold-key-whether-hydroxychloroquine-could-work-keep?video_id=6147739736001 c.. From HARVEY A. RISCH, MD, PHD , PROFESSOR OF EPIDEMIOLOGY, YALE SCHOOL OF PUBLIC HEALTH ….”The Key to Defeating COVID-19 Already Exists[ hydroxychloroquine]. We Need to Start Using It “ As professor of epidemiology at Yale School of Public Health, I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals. I am usually accustomed to advocating for positions within the mainstream of medicine, so have been flummoxed to find that, in the midst of a crisis, I am fighting for a treatment that the data fully support but which, for reasons having nothing to do with a correct understanding of the science, has been pushed to the sidelines. As a result, tens of thousands of patients with COVID-19 are dying unnecessarily. Fortunately, the situation can be reversed easily and quickly.I am referring, of course, to the medication hydroxychloroquine. When this inexpensive oral medication is given very early in the course of illness, before the virus has had time to multiply beyond control, it has shown to be highly effective, especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc. On May 27, I published an article in the American Journal of Epidemiology (AJE) entitled, “Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis.” That article, published in the world’s leading epidemiology journal, analyzed five studies, demonstrating clear-cut and significant benefits to treated patients, plus other very large studies that showed the medication safety d. Hydroxy Hysteria Reaching a Fever Pitch [Exerpts] By Brian C. Joondeph, M.D. American Thinker 7-31-20 Ever since President Trump mentioned hydroxy as a possible therapeutic, the media have castigated it as worse than rat poison. They’ve criticized any use of it in a constant barrage of fear, telling everyone that this 60-year-old drug would kill anyone who dared tak 8-e it. Hydroxy was FDA-approved in 1955 and is taken for lupus and rheumatoid arthritis. FDA approval means the approved drug is both efficacious and safe. All of a sudden, after 60 years, the FDA decided hydroxy is no longer safe because of, “serious heart rhythm problems and other safety issues, including blood and lymph system disorders, kidney injuries, and liver problems and failure.” If it is so unsafe, why did the FDA not rescind its 60-year-old approval? It is worth noting that diseases treated by hydroxy for the past half century can cause these problems as well. As can COVID, which if severe, can also cause death. So, the FDA deems it safe to treat those sick with lupus and autoimmune diseases with hydroxy but not those sick or hospitalized with COVID.Several days ago, a group of physicians called “America’s Frontline Doctors held a press conference in front of the U.S. Supreme Court building discussing the coronavirus and hydroxychloroquine. One physician in particular, Dr Stella Immanuel, gave an impassioned shout-out for hydroxy: I have personally treated over 350 patients with COVID. Patients that have diabetes, patients that have high blood pressure, patients that have asthma, old people … I think my oldest patient is 92 … 87-year old. And the result has been the same. I put them on hydroxychloroquine, I put them on zinc, I put them on Zithromax, and they’re all well. . Some studies say hydroxy doesn’t work, like giving hydroxy to patients too sick to benefit, already on a ventilator, as in the VA study. Other studies found safety concerns and were published in prestigious medical journals like The Lancet and The New England Journal of Medicine, only to be discovered to be bogus and retracted. Still other studies, as from the Henry Ford Health System noted that hydroxy cut the death rate in half. This chart from the Association of American Physicians and Surgeons shows a much lower case fatality rate in countries where hydroxy is allowed and encouraged rather than banned or discouraged. e.Hydroxychloroquine by Emily Benedek The Tablet 8-14-20 https://www.tabletmag.com/sections/science/articles/hydroxychloroquine-morality-tale Early in the coronavirus pandemic, a survey of the world’s frontline physicians showed hydroxychloroquine to be the drug they considered the most effective at treating COVID-19 patients. That was in early April, shortly after a French study showed it was safe and effective in lowering the virus count, at times in combination with azithromycin. Next we were told hydroxychloroquine was likely ineffective, and also dangerous, and that that French study was flawed and the scientist behind it worthy of mockery. More studies followed, with contradictory results, and then out came what was hailed by some as a definitive study of 96,000 patients showing the drug was most certainly dangerous and ineffective, and indeed that it killed 30% more people than those who didn’t take it. Within days, that study was retracted, with the editor of one of the two most respected medical journals in the Western world conceding it was “a monumental fraud.” And on it went. f.Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows July 02, 2020 https://www.henryford.com/news/2020/07/hydro-treatment-study DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new studypublished by Henry Ford Health System. In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020 across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19. The study was published today in the International Journal of Infectious Diseases, the peer-reviewed, open-access online publication of the International Society of Infectious Diseases (ISID.org). Patients treated with hydroxychloroquine at Henry Ford met specific protocol criteria as outlined by the hospital system’s Division of Infectious Diseases. The vast majority received the drug soon after admission; 82% within 24 hours and 91% within 48 hours of admission. All patients in the study were 18 or over with a median age of 64 years; 51% were men and 56% African American. “The findings have been highly analyzed and peer-reviewed,” said Dr. Marcus Zervos, division head of Infectious Disease for Henry Ford Health System, who co-authored the study with Henry Ford epidemiologist Samia Arshad. “We attribute our findings that differ from other studies to early treatment, and part of a combination of interventions that were done in supportive care of patients, including careful cardiac monitoring. Our dosing also differed from other studies not showing a benefit of the drug. And other studies are either not peer reviewed, have limited numbers of patients, different patient populations or other differences from our patients.” Zervos said the potential for a surge in the fall or sooner, and infections continuing worldwide, show an urgency to identifying inexpensive and effective therapies and preventions. “We’re glad to add to the scientific knowledge base on the role and how best to use therapies as we work around the world to provide insight,” he said. “Considered in the context of current studies on the use of hydroxychloroquine for COVID-19, our results suggest that the drug may have an important role to play in reducing COVID-19 mortality.” The study also found those treated with azithromycin alone or a combination of hydroxychloroquine and azithromycin also fared slightly better than those not treated with the drugs, according to the Henry Ford data. The analysis found 22.4% of those treated only with azithromycin died, and 20.1% treated with a combination of azithromycin and hydroxychloroquine died, compared to 26.4% of patients dying who were not treated with either medication. “Our analysis shows that using hydroxychloroquine helped save lives,” said neurosurgeon Dr. Steven Kalkanis, CEO, Henry Ford Medical Group and Senior Vice President and Chief Academic Officer of Henry Ford Health System. “As doctors and scientists, we look to the data for insight. And the data here is clear that there was benefit to using the drug as a treatment for sick, hospitalized patients.” Henry Ford Health System, as one of the region’s major academic medical centers with more than $100 million in annual research funding, is involved in numerous COVID-19 trials with national and international partners. Henry Ford Health System is a $6.5 billion integrated health system comprised of six hospitals, a health plan, and 250+ sites including medical centers, walk-in and urgent care clinics, pharmacy, eye care facilities and other healthcare retail. Established in 1915 by auto industry pioneer Henry Ford, the health system now has 32,000 employees and remains home to the 1,900-member Henry Ford Medical Group, one of the nation’s oldest physician groups. An additional 2,200 physicians are also affiliated with the health system through the Henry Ford Physician Network. An active participant in medical education and training, the health system has trained nearly 40% of physicians currently practicing in the state and also provides education and training for other health professionals including nurses, pharmacists, radiology and respiratory technicians. g.. Concerning Hydroxychloroquine .Everyone that I deal with says the secret of success is early use… yet all the negative reports that I’ve seen are based on relatively late use h.. My oldest granddaughter and her entire team were on a prophylactic regime of Hydroxychloroquine during their assignment to Africa. No one suffered from any side effects. i.. Encino CA Harvard Medical School MD; board certified in internal medicine and other specialties; UCLA internship and residency and now on the clinical faculty of UCLA; clinic director; in private practice including infectious diseases for more than 30 years has successfully used Hydroxychloroquine with many patients.[ current data to be obtained.] He likens its use to a fire extinguisher and says it is effective very early in the game when symptoms first appear before the virus really gets a toe hold. [“So far in my clinical experience, I can tell you that Hydroxychloroquine/Azithromycin combo has been 100% effective for my CoV patients, when used in conjunction with all of the Integrative …. I employ. Needs to be given early enough in the course of the illness to be maximally effective. Much like a fire extinguisher can put out a small kitchen fire, but if a house is engulfed in flames, you need a fire hose. Doesn’t mean fire extinguishers don’t work for house fires, just need to be used early in the event……”] j. Phoenix AZ Tufts medical school MD; board-certified in anesthesiology and pain management; clinic manager tells me that all of his associates prescribe Hydroxychloroquine and would use it in their own families. k.. Torrance CA a local physician prescribed it to both of his elderly parents [ mother late 80s, father early 90s] who tested positive for Covid-19 just before both were taken to the hospital in serious condition. Although the expectations were that one or both would die-both survived and are now both well on the road to recovery. ironically, the mother was selected for a medical test but received the placebo. Otherwise except for Hydroxychloroquine she had no other medication. The physician at the hospital claimed that Hydroxychloroquine was ineffective. The son , in a major article ,claimed otherwise. If the report was to be utilized by CDC they would take the hospital position and chalk it up that it was “ineffective.” l. Coronavirus at Texas Nursing Home – Hydroxychloroquine Treatment Saves All But 1 Patient The Resort at Texas nursing home had an outbreak of coronavirus that infected 56 residents and 33 staff members. “Two of our residents had symptoms and that’s when we tested everybody,” said nursing home Executive Director Jan Piveral. 56 residents and 33 staff members were COVID-19 positive. “Our Goal was to make sure we could shelter them in place so we don’t spread it to other people,” Armstrong said. “Then also at the same time treat them so they would get better.”Dr. Robin Armstrong immediately administered hydroxychloroquine to the residents and staff members along with Zpac and Zinc. Only one nursing home patient died since the doctor prescribed the hydroxychloroquine. 55 made it. When Armstrong began administering Hydroxychloroquine to it was controversial but appeared promising.“If we didn’t make the decision quickly then we could potentially lose 15 to 20% of the residents which was not an option,” said the Doctor. Armstrong’s approach was to begin administering Hydroxychloroquine a Zpac and Zinc just as soon as a resident first started showing symptoms.The patients were being monitored daily. “We did EKGs on each of these patients to make sure they didn’t have the cardiac side effects that everyone talks about,” Armstrong said. “None of our patients did.”Armstrong doesn’t call the Hydroxychloroquine a cure and is aware of all the recent reports that say the drug shouldn’t be used to treat COVID-19.But he points out only one of the nursing homes COVID-19 patients has died.“Everyone who got on treatment who started on treatment is actually doing really well,” he said. m. Information from Monroe, New York Since 3/15/20, my team has seen approximately 1354 patients in Monroe, New York with either test proven or clinically suspected coronavirus infection. The majority of the patients were treated with only supportive care. The patients with shortness of breath or who are in the high risk category were treated with the above regimen (approximately 405 patients at this point).. Of this group and the information provided to me by affiliated medical teams, we have had two deaths, six hospitalizations for pneumonia, and four intubations (all extubated now). In addition, I have not heard of any negative side effects other than approximately 10% of patients with temporary nausea and diarrhea. In sum, my urgent recommendation is to initiate treatment in the outpatient setting as soon as possible in accordance with the above. Based on my direct experience, it prevents acute respiratory distress syndrome (ARDS), prevents the need for hospitalization and saves lives. Conclusion: TREAT AS EARLY AND AS AGGRESSIVELY AS POSSIBLE IN THE OUTPATIENT SETTING n. MORE THAN 2,304 PHYSICIANS WHO ARE CURRENTLY SUCCESSFULLY TREATING PATIENTS INFECTED WITH THE COVID-19 REPORTED THEIR “ANECDOTAL EVIDENCE” OF THEIR SUCCESS WITH THEIR PATIENTS UTILIZING HYDROXYCHLOROQUINE An international survey conducted by Sermo, a global health care polling company, of 6,227 physicians in 30 countries found that 37% of those treating COVID-19 patients rated hydroxychloroquine as the “most effective therapy” from a list of 15 options. The survey also found that the most commonly prescribed treatments are analgesics (56%), azithromycin (41%) and hydroxychloroquine (33%). Hydroxychloroquine, which is sold under the brand name Plaquenil, was prescribed mainly in the United States for the most severe cases, but not so in other countries. “Outside the U.S., hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the U.S. it was most commonly used for high risk diagnosed patients,” the survey found. The 30 nations surveyed included those in Europe, Asia, North America and South America, as well as Australia. No incentives were provided to participate in the poll, conducted March 25-27, according to Sermo. Hydroxychloroquine usage was most widespread in Spain, where 72% of physicians surveyed said they had prescribed it, followed by Italy at 49%, and least popular in Japan, where 7% had used it to treat COVID-19. The poll found 23% of U.S. medical professionals had prescribed the drug, which has been FDA-approved for malaria, lupus and rheumatoid arthritis. Quoting Sermo CEO Peter Kirk [ which would be direct counter to Dr. Bright’s insistence that these medications be only provided to hospitalized patients] “Physicians should have more of a voice in how we deal with this pandemic and be able to quickly share information with one another and the world,” he said. “With censorship of the media and the medical community in some countries, along with biased and poorly designed studies, solutions to the pandemic are being delayed.” o. Dr. David Nazarian, Beverly Hills-based physician, diplomate at the American Board of Internal Medicine and founder of My Concierge MD: "If you look [at the] countries where malaria is more prevalent and countries where COVID-19 infections are prevalent, you will find a striking difference. This correlation needs to be explored further as this is not just a mere coincidence,” https://www.youtube.com/watchv=mV3urNCQOKM&feature=emb_logo Saturday, August 1, 2020 THIS VIDEO WAS REMOVED BY YOU TUBE B IVERMECTIN Ivermectin 'Amazingly Successful' in Killing Coronavirus By Tauren Dyson August 9, 2020 An Australian drug known as Ivermectin, which is already in use throughout the world to treat parasitic conditions, is showing great results in killing coronavirus in studies involving patients, according to Sky News. "Because I'm involved in developing these in the U.S. where all the patients are, there are a number of studies that are amazingly successful. We're talking close to 100%. In fact, we haven't seen a result yet under 100%. It looks like corona is very simple to kill," Professor Thomas Brody, medical director of Australia's Center for Digestive Disease. "It's available as a prescription medication. You wouldn't use it alone ... but you add two other things to it such as doxycycline and zinc." Ivermectin is already approved by the FDA and is on the World Health Organization's list of model list of essential medicines. "We had a 14-hospital trial in Bangladesh. We got [cured] 100 out of 100. In China, they tried to reproduce it. They got 60 out of 60 cured ... So I am behind the Ivermectin, doxycycline, zinc treatment because it has very few side effects and is a real killer of coronavirus," Borody said. Borody said the Ivermectin tablet could cost as little as $2. About Professor Thomas Borody. Professor Borody is most famous for his ground-breaking work developing the triple therapy cure for peptic ulcers in 1987, which has saved hundreds of thousands of lives, and the Australian health system more than $10 billion in medical care and operations.Professor Borody founded the Centre for Digestive Diseases (CDD) in 1984 after a distinguished career with leading hospitals including St Vincent’s in Sydney and the Mayo Clinic in the USA.He is a world-renowned leader in the clinical microbiota dating back to 1988 when he started performing what is now called Fecal Microbiota Transplantation (FMT). In addition, Dr. Borody has established novel therapies in the gastrointestinal field, including areas such as inflammatory bowel disease, irritable bowel syndrome, CDI, parasite infestation, and resistant Helicobacter pylori via a bismuth-based ‘Triple Therapy’. 9. CLOSING GENERAL OBSERVATION The single most effective way to save lives would be to improve infection control in nursing homes. Providing adequate sanitation and medical care in nursing homes should markedly reduce the covid-19 death rate. And regarding sanitation procedures ,there is a lot for our nursing home administrators and politicians to learn. An excellent source for standards and practices would be the operations of America’s pig farmers (I’m not kidding,…. read the careful procedures that America's pig farmers follow to prevent the spread of infections in their pig breeding facilities.)] unknown_1.pngunknown_2.pngunknown.jpgunknown.png